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SUMMARY 
BACKGROUND: Hypoxic-ischemic (HI) damage in neonatal brain is a major risk 
factor for different human disorders. So far, no drug is presently available to manage 
this clinical emergency, therefore, the attention of researchers working in the field 
has been given to endogenous neuroprotective strategies, in order to identify new 
druggable targets. In particular, one of the best endogenous neuroprotective 
strategies is Preconditioning (PC), which is a subliminal stimulus able to protect the 
brain from a subsequent harmful stimulus.  
AIM: The first aim of the present work was to identify a new model of hypoxic 
preconditioning. Then, we investigated whether hypoxic preconditioning (HPC) is 
able to stimulate the differentiation of neural stem cells (NSCs) in a mouse model of 
neonatal hypoxia ischemia. In addition, we investigated the relationship between the 
alteration of ionic homeostasis and the activation of endogenous neurogenesis 
mediated by NCX. The plasma membrane protein Na+/Ca2+ exchanger (NCX), whose 
activity has been linked to brain ischemic pathophysiology in adult animals. 
METHODS: Seven-day-old C57BL/6 mice were divided into different experimental 
groups. Hypoxia ischemia was induced by using Rice-Vannucci model. Briefly, they 
were subjected to ligation and cutting of the right common carotid artery followed by 
an exposure to hypoxia (92% N2 and 8% O2) at different time intervals and sacrificed 
at different times of reperfusion. Histopathological damage in the hippocampus was 
determined by measuring the expression level of Propidium Iodide (PI), whereas the 
neurogenesis was evaluated by using immunohistochemistry with different markers. 
The development of sensorimotor reflexes was examined by behavioral tests. The 
increase of NCX expression was evaluated by using immunohistochemical analyses 
in hippocampus dentate gyrus. 
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RESULTS: As expected, the greatest damage was found in mice subjected to 
ischemia plus 60‟ hypoxia (HI 60‟) and sacrificed 7 days after ischemia induction. A 
significant reduction in the hippocampal damage was observed in mice subjected to 
hypoxia for 20 minutes at postnatal day seven (P7) followed, 3 days later, by HI 60‟ 
(P10) and sacrificed at postnatal day eleven (P11). Indeed, this result suggests that 
20‟ hypoxia functions as a preconditioning stimulus. In animals subjected to hypoxic-
ischemic insult the damage was mainly localized in CA1 and CA3 regions, whereas 
the dentate gyrus was spared. Concerning the mechanism by which preconditioning 
may exert its effects, we found that preconditioning stimulus was able to trigger an 
increased expression of Nestin, a marker of neurogenesis, in seven-day-old mice. In 
addition, hypoxic preconditioning was able to determine the increase of proliferating 
cells (BrdU+/PSANCAM+) and neuroblast cells (PSANCAM+) in the dentate gyrus of 
HI 60‟ (P10) mice, sacrificed at P11. In subventricular zone hypoxic preconditioning 
determined the increase of neuroblast cells (PSANCAM+). Moreover, we observed an 
increase of NCX1 and NCX3 positive cells in dentate gyrus of preconditioned 
hypoxic-ischemic animals. Interestingly, the preconditioned hypoxic-ischemic animals 
also showed a better performance in the cliff avoidance and geotaxis reflex test than 
HI 60‟ mice.  
CONCLUSIONS: Our results indicate that hypoxic preconditioning is associated to 
endogenous neurogenesis in immature brain after insult. The increase of neurogenic 
process is probably correlated to ionic homeostasis maintenance, regulated by NCX 
proteins. Therefore, NCX proteins can represent potential pharmacological targets for 
the treatment of brain damage associated to neonatal hypoxic-ischemic 
encephalopathy (HIE).  
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1 INTRODUCTION 
1.1 NEONATAL HYPOXIC-ISCHEMIC ENCEPHALOPATHY 
(HIE) 
 
1.1.1 DEFINITION AND EPIDEMIOLOGY 
The word hypoxia indicates a state of focal oxygen deficit in brain or in other 
tissues. This condition triggers a mild or severe metabolic acidosis according to the 
duration of noxious stimulus. In case of prolonged hypoxia or global oxygen deficit, 
defined “anoxia”, there is a rapid increase of anaerobic glycolysis. Hypoxia is usually 
followed by ischemia, which consists of a reduction or block of blood flow to a tissue.  
It is well known that perinatal asphyxia (PA) and perinatal stroke are correlated, both 
events belonging to the same pathogenic process. The PA is caused by an alteration 
of respiratory gas exchange, both placental or pulmonary, and triggers the 
development of metabolic acidosis (MacLennan A., 1999). The PA can occur in three 
different moments during gestational age: before partum, during partum and after 
birth (van Handel M. et al., 2007; American College of Obstetrics and Gynecology, 
2003). Similarly to PA, the perinatal stroke occurs from the 20th week of the 
gestational age, including in utero, to the postnatal 28th day (Nelson KB., 2007). 
Perinatal stroke includes different types of insult, such as neonatal hypoxia ischemia, 
perinatal arterial ischemic stroke, neonatal cerebral sinovenous ischemic stroke, and 
presumed perinatal stroke (Fernàndez-Loòpez D. et al., 2014). In particular, perinatal 
and neonatal hypoxia ischemia represents an insult that causes acute 
encephalopathy, seizures, and severe neurologic and cognitive deficits. HIE is a 
major cause of acute mortality and chronic neurologic deficit in infants and children. 
Currently, the World Health Organization has estimated that HIE is the fifth largest 
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cause of children death, till 5 years of age (8%). Statistics suggest an occurrence of 
systemic asphyxia in 2–4 per 1000 full-term births and an incidence approaching of 
60% in premature and low weight infants (Volpe JJ. et al., 1992; Vannucci RC. et al., 
2000). Between 20–50% of asphyxiated newborns with hypoxic–ischemic 
encephalopathy die within the newborn period, and up to 25% of the survivors will 
show permanent neuropsychological handicaps, including cerebral palsy, mental 
retardation, epilepsy or learning disability (Vannucci SJ. and Hagberg H., 2004).  
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1.1.2 ETIOLOGY 
HIE is characterized by a multifactorial etiology; maternal, fetal and 
uteroplacental factors are involved in its development. During the life in utero, the 
lungs do not work yet, indeed they are not inflated, so the placenta sustains the fetus 
oxygen and carbondioxide gas exchange, in particular thanks to the chorionic villi 
which take oxygen from the mother's blood and removes carbon dioxide. The 
oxygenated blood goes through the umbilical vessels, from the maternal blood to the 
fetus; on the contrary, the two umbilical arteries carry the carbondioxide from the 
fetus blood to the mother's blood. The blood, coming from umbilical vein, passes 
through the ductus venosus (DV) or ductus Aranzio, avoiding the liver immature, and 
enters the inferior vein cava (IVC) which carries blood to the right atrium (RA) of the 
heart. Here, “ Eustacchio valve”, a wide membrane, directs the blood flow from RA to 
the left atrium (LA) through the foramen ovale (FO), which has an opening similar to 
a septal valve, excluding the pulmonary circulation (Hines MH., 2013). The blood 
through the right ventricle (RV) is pumped in the pulmonary trunk where it meets a 
second shunt, the ductus arteriosus (DA) or ductus Botallo, a short vessel which 
connects the pulmonary trunk to the aorta. As the lungs are collapsed, at high 
pressure, the blood tends to enter the systemic circulation through the DA (Hines 
MH., 2013). The aorta conveys blood to the fetal tissues. At the same time, from the 
superior vena cava (SVC) the deoxygenated blood tries to go directly through the 
tricuspid valve into the RV; this is the reason whereby it is spread in the pulmonary 
artery. However, due to the lungs are not yet inflated, the pulmonary vascular 
resistance remains strong. This fetal process allows the oxygen transport where it is 
most necessary, the heart and the brain. At birth, the placenta ceases its functions: 
the three shunts (foramen ovale, ductus venosus and ductus arteriosus) connect the 
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right side with the left side of the heart, originating a close vascular circulation (Hines 
MH., 2013). At this step, the umbilical cord is cut and the venous return from the IVC 
to the RA decreases, closing the DV. Simultaneously, the lungs start working 
increasing the venous blood flow towards the right internal. Thanks to the respiratory 
functions, the blood is oxygenated in the lungs and reach the left atrium through the 
pulmonary veins. The increasing venous blood in the lungs determines the foramen 
ovale closure interrupting the communication between the atria. Usually, within 24-48 
hours from birth, the pulmonary respiration together with the hormonal changes, the 
placenta elimination and the umbilical cord (disappearance of prostaglandins, of 
which the placenta is the biggest producer), induce the DA closure (Hines MH., 
2013). 
During the gestational age, and in the specific maternal–fetal dyad, these different 
risk factors can be connected among them, trigging pathologic changes which may 
predispose to neonatal stroke. It is well known that serious maternal factors as 
cardiac arrest, asphyxiation, severe anaphylaxis, status epilepticus, hypovolemic 
shock, severe diabetes, hypertension, and preeclampsia (Wu YW. et al., 2005) may 
cause HIE. Preeclampsia reduces placental blood flow, determining fetal cerebral 
hypoperfusion and potential emboli or ischemic injury, global or focal (Fernàndez-
Loòpez D. et al., 2014). In addition, it is known that a significant increase of the 
coagulation factors (V- VII- VIII- IX- X- XII), of the von Willebrand factor and of the 
plasma fibrinogen concentrations occurs during the pregnancy (Heier LA. et al., 
1991; Bremme KA., 2003). Concomitantly, fibrinolytic activity decreases in pregnancy 
and returns to normal values within 1 hour from the placental ejection. Consequently, 
tissue plasminogen activator decreases and PAI-1 activity increases. All these 
physiological alterations of coagulation may cause a pathological process in the 
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mother, such as thromboembolism, that in turn triggers a major risk of 
thromboembolism in the fetus (Heier LA. et al., 1991; Bremme KA., 2003). Currently, 
it is known that other factors can induce neonatal stroke, for example: the increase of 
lipoprotein (A), the presence of genetic polymorphisms of MTHFR (C677T), Factor V 
Leiden (G1691A) and prothrombin (G20210A) (Gunther G. et al., 2000; Lynch JK. et 
al., 2005). Similarly, prothrombotic states connected to neonatal stroke may be 
induced by some deficiencies such as anticardiolipin antibodies, activated protein C 
or protein S, antithrombin (Silver RK. et al., 1992; Lynch JK. et al., 2005). In addition, 
the consumption of drug abuse substances such as cocaine during pregnancy may 
cause arterial vasoconstriction and vasospasm in the fetus, especially in the first and 
third trimester (Heier LA. et al., 1991). Finally, childbirth difficulties like vacuum 
delivery and emergency Cesarean section can be associated with a major risk of 
neonatal stroke (Fernàndez-Loòpez D. et al., 2014). According to this complex 
background, it is evident that the placental abnormalities as chorioamnionitis and 
chronic poor perfusion of the placenta, with acute changes during the partum time, 
can cause the perinatal arterial ischemic stroke. In retrospective studies, examining 
the placenta of infants and children affected from cerebral palsy, including hemiplegic 
cerebral palsy, later in life, it has been observed a high incidence of chronic 
infarctions, vascular pathology and anomalies of umbilical cord (Kraus FT. et al., 
1997; Kraus FT. et al., 1999). Others risk factors are associated with fetal 
abnormalities like intracerebral hemorrhage, congenital cardiac arrhythmia, 
cardioembolic events and severe isoimmune hemolytic.  
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1.1.3 DIAGNOSIS 
Since HIE is characterized by a complex physiopathology and multifactorial 
etiology, researchers use many different criteria for studying it. In such a complicated 
clinical picture it is really important to get an early diagnosis in order to operate a 
rapid therapeutic intervention. Therefore, an appropriate neurological examination in 
the first life days is the more useful predictor for determining potential brain injury 
occurred in the perinatal period. Currently, the guidelines to diagnose a moderate or 
severe HIE, in full-term newborn and premature infants born after 34 weeks of 
gestation, is based on four essential criteria: the analysis of encephalopathy early 
signals; the analysis of metabolic acidosis; the analysis of multi-systematic organ 
dysfunction and of the brain image. In fact, to diagnose a case of perinatal asphyxia 
must be reported all of the following indicators: abnormal heart rate or meconium-
stained amniotic fluid, delay in onset of spontaneous respiration; metabolic acidosis 
(cord pH<7.0 or 7.1 and base deficit >12 mmol/l) in an umbilical artery blood sample; 
persistence of an Apgar score of <6 or 7 for longer than 5 minutes; neonatal 
neurologic sequelae (cerebral palsy, hypotonia, seizures, mental retardation, 
auditory, visual and language difficulties); multiple organ involvement (kidney, lungs, 
liver, heart, intestines); and exclusion of other etiology such as trauma, coagulation 
disorders, metabolic disorders, infections conditions and genetic disorders (American 
College of Obstetricians and Gynecologist and American Academy of Pediatrics, 
2003; Shankaran S., 2003). Therefore, the diagnosis is based on several steps 
coming in succession and according to the individual data obtained. The first aspect 
to monitor in the earliest minutes of life, in full-term infants, is the spontaneous 
respiration and the Apgar score. The Apgar score (AS) consists of a rating assigned 
at birth, expressing the vitality of the newborn and considering five vital signs which 
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are indicative of the infant‟s ability to survive on his own. A score from 0 to 2 is given 
to each of all these aspects. The evaluated aspects are following: the skin color, 
breathing, heart rate, muscle tone, reflexes. The Apgar score, which is the sum of the 
scores obtained on the five vital signs, therefore, can have a maximum of 10 points 
(newborn in excellent conditions) to a minimum of 0 points (index of serious 
difficulties at delivery). This score must be repeated twice: the first one is made about 
a minute after birth and the second time five minutes later. The identification of 
spontaneous respiration alterations and the low Apgar score must be associated with 
laboratory studies such as the analysis of serum electrolyte levels, prothrombin time 
(PT), partial thromboplastin time (PTT), and fibrinogen levels. The blood gas is 
monitored to assess acid-base status and to avoid hyperoxia and hypoxia, as well as 
hypercapnia and hypocapnia. Later, the renal parameters and cardiac and liver 
enzymes are analyzed; anomalous values can indicate the hypoxic-ischemic injury 
degree to these organs. The following step is the analysis of other molecules into the 
body fluids and, if increasing, they are, of course, disease indicators. It is well known 
that in the hypoxic brain there is an increasing expression of specific molecules, such 
as S100β, Neuron-specific enolase (NSE), Activin A, Adrenomedullin, IL-1b, and IL-6 
(Bennet L. et al., 2010). The S100β is a glial protein at low PM (10 KDa), so-called 
because of its 100% of solubility in ammonium sulfate. It is part of a multigenic 
proteins family which acts as calcium mediator (S100) (Moore BW. et al., 1965). 
Mainly, dimers localized in the cytosol, are activated by binding ionized calcium and 
regulated by cellular activities transcription, differentiation, growth and motility. It is 
expressed in the astroglial cells of CNS, in the Schwann cells, in the peripheral 
nervous system, in adipocytes, chondrocytes and melanocytes. Brain proteins are 
constituted of S100β for 0.05%. It has a neurotrophic role in physiological 
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concentration and neurotoxic effect at high concentration. NSE is a glycolytic 
isoenzyme, it is expressed only in the neurons of central and dorsal root ganglia, 
autonomic ganglia, and some peripheral neuroendocrine cells (Pickel VM. et al., 
1976; Kirino T. et al., 1983). Activin A belongs to the superfamily of Transforming 
growth factor β (TGFβ) and is composed of homodimers of subunits β, mainly 
synthesized in different areas of the central nervous system (hypothalamus, pituitary, 
olfactory bulbs). Although it has a neuromodulator role, there is evidence of activity 
as mitogen for different neuronal populations, survival nerve factor and neuronal 
differentiation inhibitor. The adrenomedullin (ADM) is a peptide hormone (52 aa). 
ADM has vasodilator and hypotensive effects, inotropic and natriuretic effects and is 
stimulated by the increase of cardiac pressure and volume overload. It is expressed 
in the cardiovascular, pulmonary, renal, gastrointestinal system, and has endocrine 
effects in brain tissue. Recent studies suggest that the plasma concentration ADM 
has increased in several diseases such as hypertension, congestive heart failure, 
chronic renal failure and septic shock (Jougasaki M. et al., 1996; Nishio K. et al., 
1997; Bennet L. et al., 2010). Its determination in plasma is limited because of its 
biological instability and its short half-life. The interleukins are cytokines secreted by 
various cells of the immune system and are the major effector molecules of 
inflammation, as they respond to different stimuli and are also present in 
inflammatory process (Bennet L. et al., 2010). The family of interleukins 1 counts 11 
active ligands on different specific receptors. IL-1β is synthesized as inactive pro-
peptide and stored in vesicles (Bennet L. et al., 2010). Inflammatory stimuli, such as 
lipopolysaccharide (LPS) and ATP, determine the maturity of the pro-peptide by the 
enzyme ICE (interleukin converting enzymes, also called caspase-1) and the 
secretion of IL-1β, that plays a crucial role in the fast response (Bennet L. et al., 
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2010). IL-6 is a cytokine produced by different cells such as macrophages, microglia, 
astrocytes etc. It has involved in the proinflammatory and anti-inflammatory 
processes. As proinflammatory molecule IL-6 is released in the peripheral region of 
the ischemic zone, in the brain of patients it can be measured in the serum where it 
can be found at high concentrations (Bennet L. et al., 2010). While, as anti-
inflammatory, it inhibits the synthesis of Tumor necrosis factor α (TNF-α) and induces 
the synthesis of the soluble receptors for IL-1 and TNF-α. In ischemia condition, the 
injection of IL-6 can induce a reduction of damage. Therefore, IL-6 has a protective 
role in cerebral ischemia (Clark WM. et al. 2000; Suzuki S. et al., 2009). All these 
markers are not characterized by high specificity because of their high concentrations 
either in physiological or in pathological conditions. Indeed, in the case of S100β it 
has been reported that an increase in several clinical conditions such as traumatic 
delivery (Schulpis KH. et al., 2006; Bennet L. et al., 2010), preterm gestational age 
(Gazzolo D. et al., 2000) as well as being affected by the sex of the infant (Gazzolo 
D. et al., 2003; Bruschettini M. et al., 2005; Vicente E. et al., 2007), pre-existing 
neural injury, intrauterine growth restriction or chronic hypoxia (Loukovaara M. et al., 
2009; Bennet L. et al., 2010), central and peripheral hypoperfusion (Routsi C. et al., 
2006), treatments such as prenatal maternal glucocorticoids and anesthetics infant 
(Bruschettini M. et al., 2005; Vicente E. et al., 2007), perinatal infection/inflammation 
(Bokesch PM. et al., 2002; Friel LA. et al., 2007; Garnier Y. et al., 2009). 
Furthermore, S100β and NSE may be released from the umbilical cord and placenta, 
not only in the brain (Wijnberger LD. et al., 2002). Up until now, it has not been 
defined the precise time window in which S100β reaches a pick, in the disease case. 
The severity levels of the disease are not always correlated with the different S100β 
concentration. The analysis of these parameters can predict the evolving injury in a 
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timely manner. To have a complete and quick diagnosis it is necessary to examine 
instrumental analysis and biomarker data at the same time. Potential affect subjects 
to echocardiography (ECC), to highlight anomalies heart like congenital cardiac 
arrhythmia. Electroencephalography (EEG), standard and amplitude-integrated EEG, 
are fundamental in the fetuses who developed severe brain injury, the EEG remains 
highly abnormal (Bennet L. et al., 2010). An epileptiform EEG transients can be 
found in preterm infants (Scher MS. et al., 1994; Vecchierini-Blineau MF. et al., 1996; 
Bennet L. et al., 2010) and high levels of these transients are associated with 
adverse neurodevelopmental outcomes (Scher MS. et al., 1994; Okumura A. et al., 
2003; Bennet L. et al., 2010). In addition, the EEG features may also have prognostic 
value, for example, the variation of the power spectrum (Wong FY. et al., 2007; 
Bennet L. et al., 2010), evaluation of nonlinear quantitative EEG measures of 
frequency (Doyle OM. et al., 2007), and long-range correlations in sub-band EEG 
signals by detrended fluctuation analysis (DFA) may be predictive of outcome and 
the phase of injury (Jiang D. et al., 2009; Bennet L. et al., 2010). Conventional EEG 
(cEEG) and amplitude-integrated EEG (aEEG) are performed in the early neonatal 
period and are highly predictive regarding the long-term outcomes (Obrecht R. et al., 
1982; Murray DM. et al., 2009; Bennet L. et al., 2010). Finally, the diagnostic and 
prognostic capacity of the EEG may be improved when combined with other markers, 
such as the cerebral oxidative metabolism measure (Tichauer KM. et al., 2009). 
Other investigations consist of Magnetic resonance imaging (MRI) of the brain, 
Cranial ultrasonography, Computed tomography (CT) scanning of the head. During 
an MRI, pictures are taken from the top of the skull to the base and from the front to 
the rear. Scanning resumes, therefore, all the areas of the brain allowing the analysis 
of each layer. When the brain is damaged, the lesioned area will form a scar; parts of 
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the brain that have suffered injuries/scars give off a high signal (hyperintense signal) 
which differentiate them from normal tissue. Generally, hypoxic-ischemic lesions are 
detected on magnetic resonance through 4 signals: signal strength increased in the 
basal ganglia; signal strength increased in the thalamus; signal strength absent or 
reduced in the back of the internal capsule (white matter structure that carries 
information over the basal ganglia); dissemination of liquid reduced the diffusion 
weighted images (Bennet L. et al., 2010). Cranial ultrasonography (ultrasound) is not 
able to capture all anomalies associated to hypoxic-ischemic encephalopathy. 
However, it can detect bleeding and the size of the ventricle, the white matter and 
parasagittal prominent cystic lesions. Ultrasound can be used to detect cerebral 
edema within 24 hours of hypoxic-ischemic insult, and the results include an overall 
increase of echogenicity (Bennet L. et al., 2010). These analyses allow the 
determination of injured areas, providing indicative information about the entity of 
hypoxic- ischemic event occurred. It is well known that the pathologic lesions and the 
resulting remote outcomes are different in term newborns compared to preterms. In 
the first case the lesions are localized in the gray matter; in the preterms the white 
matter is damaged. Finally, it is necessary to perform retinal and ophthalmic 
examination, and the pediatric Hearing test. It is an audiometric test that allows to 
evaluate of person's hearing ability by measuring the sound capacity to reach the 
brain. This test is performed considering that an increased deafness incidence has 
been found among infants affected by hypoxic-ischemic encephalopathy who require 
assisted ventilation. 
In clinical practice and for scientific purposes, thanks to an encephalopathy score, it 
is possible to classify potential HIE affected people. Several classification systems 
elaborated by Leviton and Nelson provide an overview of qualitative and quantitative 
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grading schemes. In particular, in 1976, Sarnat and Sarnat developed the most 
common classification system of disease severity levels, on which is based the 
modern examination practice. According to the Sarnat system, children assignment is 
a score of 1, 2 or 3 (1=mild HIE; 2= moderate HIE; 3= severe HIE). In the mild HIE, 
during less than 24 hours, it is observed hyperalertness, stretch reflexes, sympathetic 
effect, a normal EEG. In the moderate HIE, it is observed an obtundation, hypotonia, 
strong distal flexion and multifocal seizures. Infants show a severe HIE present 
flaccidity and the suppression of brain stem and autonomic functions. In according to 
these symptoms the EEG is characterized by abnormal patterns of brain activity. To 
obtain an early diagnosis we have to start from the clinical symptoms to identify 
cases of cerebral palsy, learning disabilities, and complex behavioral disorders 
developing later in childhood. However, Sarnat grading is a valid predictive 
classification system in infants with mild and severe encephalopathy (van de Riet JE. 
et al., 1999; Haataja L. et al., 2001; Van Schie PEm. et al., 2010). In these cases 
neonatal MRI has demonstrated a high sensitivity but a lower specificity for predicting 
good motor outcomes (Keeney SE. et al., 1991; Kuenzle C. et al., 1994; Van Schie 
PEm. et al., 2010), therefore, children with normal MRI usually have a favorable 
motor outcome (Haataja L. et al., 2001; Belet N.et al., 2004; Miller SP. et.al., 2005; 
Van Schie PEm. et al., 2010). Thus, Sarnat grade I and normal neonatal MRI 
accurately predicts a good motor outcome after neonatal hypoxic-ischemic insult, 
whereas Sarnat grade II and abnormal MRI predicts a poor outcome with less 
accuracy. So children with abnormal MRI and altered motor abilities need routinely 
control concerning their neurological and psychomotorial conditions. Many of these 
periodical clinical assessments are most sensitive to injury severity beyond the 
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narrow time window for the treatment beginning (i.e. later than 6 h) (Sarnat HB. and 
Sarnat MS., 1976). 
 
Table 1. Sarnat scoring scale (Sarnat HB. and Sarnat MS., 1976).  
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1.1.4 PATHOPHYSIOLOGY AND MECHANISMS OF CELL DEATH 
Hypoxic-ischemic encephalopathy is caused by the reduction of cerebral blood 
flow (CBF) to the brain (Ferriero DM., 2004; Perlman JM., 2004), that in turn is due to 
the alteration of respiratory gas exchange, both placental or pulmonary. In the first 
phase of insult the organism induces different responses to attenuate the damage in 
brain, heart, and adrenal glands. At first CBF increases, then there is a lowering of 
brain temperature and release of gamma-aminobutyric acid (GABA) neurotransmitter. 
In the cells an increase of anaerobic glycolysis occurs, this triggers the accumulation 
of lactate, which determines the typical acidosis.  
 
 
1.1.4.1 EXCITOTOXICITY 
Cell death process triggered by HIE can be divided into two main phases. In 
the early phase there is a progressive cell depolarization (Gunn AJ. et al., 1997; 
Davidson JO. et al., 2015), and the accumulation of excitatory amino acids, which 
causes necrotic cell death (Tan WK. et al., 1996; Davidson JO. et al., 2015). In the 
second phase there is a great release of free radicals (FR), the activation of 
excitotoxic pathways, and nitric oxide production induced by reperfusion (Juul SE. 
and Ferriero DM., 2014). These events determine the necrotic and apoptotic death of 
a large number of cells. In the second phase of prolonged hypoxia or HI injury, the 
alteration of cellular energy (ATP) induces the depolarization of neurons and glia and 
the release of excitatory amino acids (EAA) into the extracellular space (Vannucci 
SJ. and Hagberg H., 2004). In the central nervous system the excitatory 
neurotransmission is mainly related to glutamate activity. Glutamate interacts with 
two classes of receptors: ion channels and metabotropic receptors (mGluR) 
(Palmada M., et al. 1998; Kleman NW. et al., 2010). It is well known that glutamate is 
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an important trophic factor for the immature brain, besides it plays a key role in 
development, differentiation, migration and survival affecting progenitor cell 
proliferation (Kleman NW. et al., 2010). In particular, during hypoxic-ischemic events 
there is a strong activation of N-methyl-D-aspartate (NMDA), alpha-3-amino-hydroxy-
5-methyl-4-isoxazole propionic acid (AMPA), and kainate receptors (Gucuyener K. et 
al., 1999; Juul SE. and Ferriero DM., 2014). The great activation of NMDA receptors 
causes the increase of intracellular levels of calcium, and consequently it triggers the 
pro-apoptotic pathways mediated by caspase-3. Finally, the alteration of nuclear 
structure and DNA damage occur (Juul SE. and Ferriero DM., 2014). All these events 
cause a profound lesion in the developing brain, and most of the cells undergo death 
for necrosis or apoptosis. In 1969, Onley and Sharpe were the first to introduced the 
concept of “excitotoxicity”, demonstrating that neurons exposed to their own 
neurotransmitter glutamate could die (Olney JW. and Sharpe LG., 1969). Later on, it 
has been demonstrated that during anoxia, glutamate is released in extracellular 
compartments and determines neurotoxic effects, triggering a great influx of Ca2+ and 
Na+ ions into neurons through its receptors (Choi DW., 1998). Recently, this theory 
has become the object of different criticisms, because it can only explain some 
events occurring in the acute phase of anoxic insult (Di Renzo Gf. et al., 2009). In 
addition, it has been demonstrated that the new generations of glutamate receptor 
antagonists were not able to protect the brain in animal models of brain ischemia and 
in human stroke (Di Renzo Gf. et al., 2009).  
The limits of this theory can be summarized in the “Hossmann postulates”: 
1. Glutamate exposition and ischemic injury induce different metabolic and 
biochemical response. In fact, after ischemia there is a suppression of energy 
metabolism and occurs changes in protein synthesis (Djuricic B. et al., 1994). 
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In contrast, the exposure to a high dose of glutamate does not change energy 
metabolism and protein synthesis (Hossmann KA., 1993). This aspect 
indicates that the exposition of high dose of glutamate is able to preserve the 
proteins from stroke, so it indusces a different damage compared to brain 
ischemia (Di Renzo Gf. et al., 2009). 
2. In experimental models of brain ischemia, the glutamate levels have been 
measured after insult, demonstrating that the increase of glutamate is not 
necessarily required for induction of pathological process (Di Renzo Gf. et al., 
2009). 
3.  During ischemia in core region the neuronal death is mainly due to energy 
depletion, in contrast, in penumbra area the damage can be mediated by the 
exposition of glutamate toxicity (Kaku DA. et al., 1993). 
4. The structural integrity of ischemic penumbra is fully preserved, therefore, 
excitotoxicity induced by glutamate is not possible in this area (Di Renzo Gf. et 
al., 2009). 
5. Phenomenon of glutamate toxicity has a complete evolution 24 hours after 
insult in vitro experimental studies (Choi DW. et al., 1987), in contrast, in vivo it 
has a complete evolution after 6 hours. Therefore, at same time point, the 
penumbra area becomes the ischemic core (Back T. et al., 1994). 
6. During ischemic event occurs a greater release of inhibitory neurotransmitters 
(GABA) than glutamate in blood flow, therefore, there is a strong reduce of 
excitotoxicity (Matusumoto K. et al., 1993). 
In conclusions, preclinical studies have suggested that NMDA antagonists are 
protective in focal ischemia only if administered immediately after insult (Di Renzo Gf. 
et al., 2009). 
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1.1.4.2 NON-NMDA DEPENDENT PATHWAYS 
Beside glutamate receptors, other membrane proteins involved in ionic 
homeostasis maintenance have been linked to stroke pathophysiology. Among these 
are listed: NHE, NCX, NCca-ATP. The plasma membrane Na
+/H+ exchanger (NHE) and 
H+ pump are activated to remove the excess of H+ ions. NHE regulates intracellular 
pH (pHi) homeostasis and cell volume. Nine isoforms have been cloned, which have 
different subcellular distribution, kinetic properties, and physiological functions (Xue 
J. and Haddad GG., 2009). NHE isoform 1 is expressed in all central nervous system 
(CNS) and is associated with several pathophysiological conditions (Ma E. and 
Haddad GG., 1997; Luo J. and Sun D., 2007; Kleman NW. et al., 2010). It is 
activated by ischemia and induces an increase of intracellular Na+ ions, which 
promotes Ca2+ influx by reverse mode operation of the Na+/Ca2+ exchanger (NCX) 
(Lee C. et al., 2005; Kintner DB. et al., 2007; Kleman NW. et al., 2010). The great 
increase of intracellular Ca2+ levels and the consequent cell death may involve in the 
activation of apoptotic mitochondrial pathway, changes of pHi, brain edema; 
activation of Mitogen-activated protein kinases (MAPKs); and release of excitatory 
amino acids and ROS. During neonatal HI, the non-selective NCCa-ATP cation channel 
contributes to edema formation (Pedersen SF. et al., 2006). The NCCa-ATP channel 
conducts monovalent cation currents and requires nanomolar concentrations of Ca+ 
to open (Chen M. et al., 2001; Kleman NW. et al., 2010). Sulfonylurea receptor 1 
(SUR1) regulates this channel, that is activated by depletion of intracellular ATP. In 
adult animal models, the blockade of SUR1 by glibenclamide reduced cerebral 
edema, infarct volume and mortality by 50% (Simard JM. et al., 2006; Kleman NW. et 
al., 2010). In contrast, in a neonatal rat model of HI, glibenclamide is able to protect 
the brain from moderate insult only (Luo J. and Sun D., 2007; Kleman NW. et al., 
2010).  
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1.1.4.3 OXIDATIVE STRESS 
The excitotoxic pathways are directly involved in the activation of neuronal 
nitric oxide synthase (nNOS) and the generation of nitric oxide. The increase of 
intracellular levels of NO induces mitochondrial dysfunction and formation of reactive 
oxygen species (ROS) (Vannucci SJ. and Hagberg H., 2004). The ROS include 
superoxide anion (O2-), hydroxyl radical (OH), and hydrogen peroxide (H2O2). All 
these substances have as target, lipids, proteins and DNA. The damage of these 
cellular components causes cell death. During oxidative stress, cytoplasmic 
superoxide dismutase (SOD1) and mitochondrial superoxide dismutase (SOD2) are 
activated in brain (Vannucci SJ. and Hagberg H., 2004). SOD enzymes convert the 
oxygen free radicals in H2O2, which can be detoxified by catalase or glutathione 
peroxidase and eliminated as H2O (Vannucci SJ. and Hagberg H., 2004). Therefore, 
the alteration of antioxidant system contributes to the increase of brain damage 
induced by hypoxic-ischemic injury.  
 
 
1.1.4.4 INFLAMMATION 
During cerebral ischemia, in both the parenchyma and the systemic circulation 
the inflammatory response is activated. In neonatal hypoxia ischemia, even minutes 
after the insult intervenes an immediate innate immune response (Algra SO. et al. 
2013; Liu F. et al., 2013). In particular, the cytokines, important inflammatory 
mediators, are release in situ of inflammatory reaction (Saliba E. et al., 2001; Liu F. 
et al., 2013) and maintain brain tissue homeostasis (Hopkins SJ., 2003; Liu F. et al., 
2013). In general, the roles of cytokines are pleiotropic, and they can have both pro- 
or anti-inflammatory effect in the context of ischemic insult. The cytokines related to 
the inflammatory responses to stroke are interleukins (IL-1, IL-6, IL-10), tumor 
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necrosis factor-α, and transforming growth factor-β (Han HS. et al., 2003; Liu F. et 
al., 2013). In the CNS, IL-1β and TNF-α are produced by microglia, astrocytes, and 
neurons, these cytokines are characterized by potent pro-inflammatory effects. In 
peripheral blood samples of human newborns affect by HIE (at P1, P3, and P7) were 
found higher levels of IL-1β and TNF-α than controls (Liu J. et al., 2010; Liu F., et al., 
2013). 
 
 
1.1.4.5 NECROSIS AND APOPTOSIS 
Hypoxic-ischemic injury induces necrotic and apoptotic cell death. Both can be 
classified on the basis of biochemical and morphological criteria (MacManus JP. and 
Linnik MD., 1997; Vannucci SJ. and Hagberg H., 2004). Necrotic death is induced by 
severe hypoxic-ischemic insult and is characterized by the disruption of membrane 
integrity, the release of cytoplasmic molecules into the extracellular space and a 
secondary inflammatory response (Vannucci SJ. and Hagberg H., 2004). In contrast, 
programmed cell death or apoptosis is a regulated cell commit suicide. The process 
is regulated by a family of cysteine proteases, called caspases. Caspase-3 is 
involved in the cleavage of different substrates that are vital for cell survival (Cohen 
GM., 1997; Vannucci SJ. and Hagberg H., 2004). Caspase-3 is activated by intrinsic 
or extrinsic pathways. The activation of intrinsic pathway induces the release of 
cytochrome c and formation of the apoptosome and, subsequently, caspase-9 
activation. The activation of extrinsic pathway mediates the binding between specific 
ligands and their receptor, known as death receptors. In particular, the FAS-ligand 
binds the FADD-receptor, which leads to caspase-8 cleavage and activation of 
caspase-3 (Vannucci SJ. and Hagberg H., 2004). In the neonatal hypoxic-ischemic 
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brain the apoptosis is the main cell death mechanism (McDonald JW. et al., 1997; 
Kleman NW. et al., 2010). Northington and his colleagues demonstrated that in the 
early hours after HI induction there was a great number of necrotic cells in the 
ipsilateral forebrain, in the striatum and cortex of P7 rats (Northington FJ. et al., 2001; 
Kleman NW. et al., 2010). While the number of apoptotic cells increased in ipsilateral 
ventral basal thalamus and in the ipsilateral cortex respectively at 24 and 48 hours 
after induction of insult (Northington FJ. et al., 2001; Kleman NW. et al., 2010). 
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1.1.5 THERAPY IN HIE 
Early diagnosis of hypoxic ischemic encephalopathy is extremely important 
because timely treatment may reduce the devastating effects of the insult. Currently, 
in the neonatal intensive departments in case of suspicion of HIE insult, vital signs 
together with of biochemical and blood gas values are monitored, resulting in 
correction of metabolic changes. In particular, clinical procedures provide 
resuscitation and stabilization, the possibility to proceed with artificial ventilation, 
monitoring of blood pressure (BP), trying to maintain above 35-40 mmHg, checking 
of fluid and levels of glycemia. Nowadays, the therapies used have been suggested 
by international protocols, and their effectiveness depends on the fact that they must 
be administered in a given time frame from the insult. 
 
 
1.1.5.1 ANTI-EXCITOTOXIC AGENTS 
In the early phase of hypoxic-ischemic insult the infants are treated with anti 
excitotoxicity agents. In 1990, Grigg and Anderson reported that the use of 
competitive and noncompetitive NMDA receptor antagonists, in rat hippocampal 
slices, was able to ameliorate the hypoxia-induced functional failure (Grigg JJ. and 
Anderson EG., 1990; Villa RF. and Gorini A, 1997). Recent clinical trials conducted in 
Australia and in the USA supported the use of antenatal magnesium. In particular, in 
New Zealand, woman at 30 gestation weeks were subjected to infusion of 16 mmol 
of MgSO4 followed by 8 mmol for up to 24 hours, this study demonstrated that 
MgSO4 reduced death or determined substantial gross motor dysfunction, but there 
were not any significant differences in mortality rate or cerebral palsy in survivors. In 
the USA, it has been demonstrated that the use of MgSO4, in the perinatal period, 
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reduced the negative effects of severe cerebral palsy (CP) (Costantine MM. et al., 
2011; Juul SE. and Ferriero DM., 2014). 
It is well known that the noble gas Xenon is an antagonist of the NMDA receptors. 
During hypoxic condition, Xenon induces the increase of Hypoxia-inducible factor 1α 
(HIF-1α) expression (Ma D. et al., 2009; Juul SE. and Ferriero DM., 2014); and so 
the upregulation of erythropoietin (Epo), vascular endothelial growth factor (VEGF) 
and glucose transporter 1 protein (Ma D. et al., 2009; Juul SE. and Ferriero DM., 
2014).  
 
 
1.1.5.2 ANTI-OXIDANT AGENTS 
In the early phase of hypoxic-ischemic insult the infants can be also treated 
with anti-oxidant agents. Allopurinol is a xanthine-oxidase inhibitor, at high 
concentrations it inhibits the formation of free radical. In preclinical studies in 
postnatal seven-day rats after HI, administration of allopurinol (135 mg/kg 
subcutaneously) 15 min after cerebral hypoxia ischemia, reduced brain edema and 
attenuated long-term brain damage (Palmer C. et al., 1993; Juul SE. and Ferriero 
DM., 2014). The use of allopurinol in humans have been reported in several clinical 
trials. In some of them allopurinol was assumed by mothers of fetuses with a 
suspected intrauterine hypoxia (Kaandorp JJ. et al., 2010; Torrance HL. et al., 2009). 
In each trial a specific marker was monitored during the gestational age, the health of 
newborns was monitored up to two years. These studies showed that there was an 
increase of marker levels in cord blood of newborns affected by hypoxia ischemia at 
N36 weeks gestation (Torrance HL. et al, 2009). Recently, it has been demonstrated 
that a new class of oxygen free radical scavenging agents, non-glucocorticoid 21-
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aminosteroids, has a protective role in cerebral ischemia models (Perkins WJ. et al., 
1991; Villa RF. and Gorini A, 1997).  
 
 
1.1.5.3 ANTI-INFLAMMATORY AGENTS 
Recent studies showed the neuroprotective role of melatonin in white matter 
and learning disabilities. In vivo model, it has been demonstrated that blocking of 
melatonin release produces a substantial white matter injury (Welin AK. et al., 2007; 
Juul SE. and Ferriero DM., 2014). It has been observed that a significant reduction of 
melatonin induced the activation of microglia in the neonatal model of hypoxia 
ischemia (Villapol S. et al., 2011; Juul SE. and Ferriero DM., 2014). In piglet model it 
has been demonstrated that melatonin, in combination with hypothermia, preserves 
brain function measured by aEEG, and reduced cell death in the thalamus, the region 
most affected by the asphyxia insult (Robertson NJ. et al., 2013, Juul SE. and 
Ferriero DM., 2014) Moreover, it has been reported that Omega-3 polyunsaturated 
fatty reduces brain damage and improve neurological functions in HI mice after insult. 
The Omega-3 compound works as inhibitor and prevents the release of inflammatory 
mediators (Zhang W. et al., 2010; Juul SE. and Ferriero DM., 2014). In rodent model 
of HI, it has been demonstrated that the administration of ibuprofen daily for 1 week 
determined the reduction of brain injury, because the drug contrasted the effects of 
inflammatory mediators (Wixey JA. et al., 2012). 
 
 
1.1.5.4 ANTI-CONVULSANT AGENTS 
Up until now, it is well known that moderate and severe hypoxic-ischemic 
insult are always accompanied by seizures, resulting in a deterioration of the cerebral 
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lesions, therefore, the effective prevention of neonatal seizures could attenuate brain 
injury. Anticonvulsant drugs (AEDs) are a heterogeneous class of drugs useful to 
suppress repetitive neuronal depolarization and high frequency that evoke seizures. 
Many of these drugs act by affecting the conductance of K+, Na+, Ca2+ and thus 
interfere with neurons membrane potentials. In addition, they prevent the spread of 
neuronal depolarization within the brain and offer protection against brain damage 
caused by seizures. Currently, topiramate and levetiracetam are indicated for the 
treatment of perinatal asphyxia affections (Kim JM. et al, 2009). Topiramate (TPM) is 
a monosaccharide substituted, characterized by good absorption, high bioavailability, 
and good tolerability. TPM possess different mechanisms of action: (I) inhibits 
AMPA/kainate (Follett PL. et al., 2004; Kaminski RM. Et al., 2004; Koh S. et al., 
2004; Angehagen M. et al., 2005; Sfaello I. et al., 2005; Filippi L. et al., 2012), (II) 
blocks the pre-synaptic voltage-sensitive Na+ channels of excitatory synapses (Zona 
C. et al., 1997; Filippi L. et al., 2012), (III) blocks the high voltage-activated calcium 
currents (Costa C. et al., 2006; Filippi L. et al., 2012), (IV) impairs mitochondrial 
permeability transition pore (MPTP) (Kudin AP. Et al., 2004; Filippi L. et al., 2012), 
(V) inhibits carbonic anhydrase isoenzymes (Dodgson SJ. et al., 2000; Filippi L. et 
al., 2012), and enhances GABA-mediated chloride flux and GABA-evoked chloride 
currents in murine brain neurons, thus increase seizure threshold (White HS. et al., 
1997). In animal models of HI (postnatal day 7), it has been demonstrated that the 
immediate administration of TPM after injury induces neuroprotection, mainly 
because of the AMPA-kainate activity reduction (Follett PL. et al, 2004). In neonatal 
stroke model, the effects of TPM treatment were observed in multi-strategy therapies. 
The combined treatment of TPM and hypothermia conferred protection, improving 
functional performance better than hypothermia alone (Liu Y. et al., 2004; Cilio MR. 
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et al., 2010). Notably, the combined treatment of TPM, levetiracetam and phenytoin 
induced the increase of cell death, in contrast, TPM and levetiracetam treatment 
reduced the brain injury (Kim J. et al., 2007a). It has been reported that levetiracetam 
has a good efficacy in seizure treatment (Mazarati AM. et al, 2004) and reduced the 
infarct volume in focal ischemia (Hanon E. and Klitgaard H., 2001).  
 
 
1.1.5.5 ERYTHROPOIETIN  
Erythropoietin (Epo) is a glycoprotein hormone, produced in humans mainly by 
peritubular interstitial cells of kidneys, that perceive the alterations of oxygen levels in 
organism. Therefore, the Epo production is regulated by a sensitive feedback 
system. During hypoxic condition, HIF-1α translocates from the cytoplasm to the 
nucleus, where it dimerizes with HIF-1β, generating the heterodimeric complex (HIF-
1α and HIF-1β), able to bind to hypoxia response element (HRE) in the 3‟ enhancer 
of the gene for erythropoietin, finally inducing the increase of expression of Epo gene 
(Wang GL. et al., 1995; Ke Q. and Costa M, 2006). The increase of Epo expression 
stimulates the rapid expansion of erythroid progenitors. Conversely, during normoxic 
conditions, HIF-1α is rapidly degraded by prolyl-hydroxylase. The Epo acts in bone 
marrow hematopoietic framework by stimulating the colony forming unit-erythroid 
(CFU-E), reducing apoptosis and increasing the frequency of mitosis (faster 
differentiation in proerythroblast). It is well known that in humans and murine brain, 
during both fetal development and adult life, a local production of Epo occurs (Juul 
SE. et al., 1998; Juul SE. et al., 1999). Epo binds to its specific receptor, 
Erythropoietin receptor (EpoR), expressed on the surface of the membranes. EpoR is 
a transmembrane glycoprotein, that is a component of cytokine type I receptor 
superfamily; it is expressed on erythroid cells but also on the different brain cells, 
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such as glial cells (Nagai A. et al., 2001), neurons (Morishita E. et al., 1997), 
endothelial cells (Yamaji R. et al., 1996), of different brain regions, such as 
hippocampus, cortex, internal capsule and midbrain (Digicaylioglu M. et al., 1995). 
Binding of Epo on its receptor determines the homodimerization and activation of the 
same receptor. This, in turn, leads to the activation through phosphorylation of 
receptor associated to tyrosine kinase (Janus Kinase 2); phosphorylation and 
activation of MAPK, extracellular signal regulated kinases (ERK1/2), as well as the 
phosphoinositide 3-kinase and protein kinase B (PI3K/Akt) pathway and signal 
transducer and activator of transcription (STAT5). All these pathways are involved in 
the activation of anti-apoptotic pathways, that induces the expression of anti-
apoptotic Bcl-xl (Bcl2 family member), which mediates protective effects on neurons 
and oligodendrocytes (Digicaylioglu M.et al., 2001; Juul SE. and Ferriero DM., 2014). 
In particular, Epo signaling inhibits early mechanisms of brain injury by its anti-
excitotoxic (Zacharias R. et al., 2010), anti-oxidant (Kumral A. et al., 2005) effects. In 
neonatal hypoxic-ischemic model, it has been demonstrated that the administration 
of high doses of Epo decreased the brain damage, reducing neuronal loss, improved 
the functional activities, and promoted neurogenesis and oligodendrogenesis 
(Gonzalez FF. et al., 2007; Iwai M. et al., 2007). Epo also protected the vascular 
integrity of capillaries following injury through VEGF (Bocker-Meffert S. et al., 2002; 
Ke Q. and Costa M, 2006; Wang L. et al., 2008) and participated in preservation of 
the blood-brain barrier (Marti HH. et al., 2000; Ribatti D. et al., 2003; Ke Q. and Costa 
M, 2006). In addition, it has been demonstrated that Epo also mediated the anti-
inflammatory effects, in fact, it reduced the activation of astrocytes reactive cells, 
microglia, immune cells and relation of inflammatory cytokines in the damaged area 
(Sun Y. et al., 2005; Juul SE. et al., 2009). Recently, it has been demonstrated that 
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recombinant Epo and the mimetic drugs reduction brain damage in neonatal hypoxia 
ischemia (Sola A. et al., 2005; Kellert BA. et al., 2007; Traudt CM. et al., 2013) and in 
intraventricular hemorrhage or periventricular leukomalacia (Kumral A. et al., 2007). 
The drugs do not cause problem also in high dose (McPherson RJ. et al., 2007) and 
are able to pass the blood-brain barrier. In particular, the administration of Epo doses 
of 1000-5000 U/kg/dose resulted in sustained neuroprotection, improving both short 
and long-term structure and function. Encouraging data on animal models induced to 
the translation on clinic trials; this trials should not be used in prenatal time because 
the Epo doesn‟t cross placenta. Nowadays, there are Phase I/II trials, which tend to 
establish Epo safety and translational pharmacokinetics profiles in preterms 
(Fauchere JC. et al., 2008; Juul SE. et al., 2008) and term neonates (Wu YW. et al., 
2012). In addition, there are trials that analyze the effect of combination of Epo or 
darbepoetin with hypothermia in term HIE, however, data are not also clear. 
 
 
1.1.5.6 HYPOTHERMIA  
Therapeutic hypothermia represents the first accepted treatment able to 
attenuate brain injury in neonatal HIE (Walsh BH. et al., 2011). Nevertheless, the 
mechanisms involved in hypothermic neuroprotective effect are not fully known. The 
neuroprotective effect of hypothermic treatment has been demonstrated in neonatal 
animals that were subjected to a protocol of controlled cooling to 33–34 C°, within 6 
hours at HIE insult, and were maintained at this temperature for 72 hours (Azzopardi 
DV. et al., 2009). This treatment inhibits many of the processes involved in primary 
and secondary energy failure (Laptook AR., 2009b). Moreover, it has been observed 
in rats, that hypothermia induces neuroprotection in hippocampus, through an 
increased expression of glial cells line-derived neurotrophic factor (GDNF), and with 
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the decrease of expression of TNFα and IL-6 and their mRNA levels (Xiong M. et al., 
2009; Kleman NW. et al., 2010). Therefore, in neonatal model of HI the hypothermic 
treatment determines the inhibition of inflammatory response astrocyte, due to the 
reduction of glial fibrillary acidic protein (GFAP) levels (Xiong M. et al., 2009; Kleman 
NW. et al., 2010). Thus, a rapid and accurate diagnosis allows only the cooling of 
infants with moderate to severe HIE (Azzopardi DV. et al., 2009). 
Currently, in HIE affected seven clinical trials on the therapeutic efficacy of 
hypothermia have been analyzed (Gluckman PD. et al, 2005; Azzopardi DV et al, 
2009; Simbruner G. et al, 2010; Zhou WH. et al, 2010). These trials are characterized 
by stringent inclusion criteria. The infants must have been born at least after 36 
weeks of gestation. They must have a weight of 1800-2000 g at birth. The newborn 
must show evident clinical signs, such as Apgar score of 5 or less at 10 minutes after 
birth, severe acidosis (pH<7), lethargy, coma, abnormal tone or posture, abnormal 
reflexes (stretch reflexes, grasp, Moro). In addition, the affected must have 
bradycardia, abnormal pupils, apneas and an alteration of aEEG.  
In particular, Azzopardi et al. performed a randomized trial on asphyxiated newborns 
at 36 weeks of gestation. The affected were divided into two groups: the first group 
was subjected, within 6 hours from the birth, at cooling of the body to 33.5°C for 72 
hours plus intensive care, while the second group was subjected to intensive care 
only. They demonstrated that the hypothermic treatment improved only neurologic 
functions in the first group compared with the second one (Azzopardi DV et al, 2009). 
The infants were monitored until 18 months of age.  
In contrast, Zhou et al. demonstrated that the HIE newborns subjected to cooling at 
temperature of 34.5°± 0.2°C for 72 hours, 6 hours after birth, showed a decrease of 
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the combined death and severe disability (Zhou WH. et al, 2010). The infants were 
monitored until 18 months of age.  
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1.2 ANIMAL MODELS OF NEONATAL WHITE MATTER 
INJURY (WMI) 
Currently, the mechanisms involved in HIE pathophysiology, are not 
completely known as the experimental models are not able to reproduce the complex 
background of this disease. The majority of the available information has been 
obtained thanks to the use of hypoxic-ischemic animal models. In the most part of 
these experimental studies a model of unilateral hypoxic–ischemic brain damage has 
been utilized in immature rat (Rice JE. et al., 1981; Vannucci RC. et al., 1996; 
Vannucci RC. et al., 1997). Recently, this model has been extended to immature 
mouse (Sheldon RA. et al., 1998). In the latest years, from this model other animal 
models have been developed in order to mimic the different pathophysiological 
features of the perinatal brain injury.  
 
 
1.2.1 RICE AND VANNUCCI MODEL 
The first model of neonatal HI was developed by Vannucci and Rice in rats 
(Rice JE. et al., 1981). The Vannucci/Rice method consists of an unilateral carotid 
artery ligation carried out in postnatal day seven rats followed by exposure to 8% 
oxygen/balanced nitrogen at 37°C. The unilateral carotid artery ligation alone does 
not induce ischemic damage because the circle of Willis maintains the reoxygenation 
of brain tissues. In contrast, the unilateral common carotid ligation and the exposition 
to 8% oxygen induce to hypoxemia and hypocapnia produced by hyperventilation 
(Vannucci RC. et al., 2005). These events cause the activation of anaerobic 
glycolysis and the lactic acid accumulation. It is well known that this model 
reproduces the damage to ipsilateral hippocampus, striatum, thalamus and cortex 
(Welsh FA. et al., 1982). In rats, the model is reproduced at P7, which correlates 
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histologically to a 32 to 34 week human neonate (Vannucci RC. et al., 2005). In mice, 
the model is reproduced at P7 to P10 (Barks JD. et al., 2008; Doverhag C. et al., 
2008; Stone BS. et al., 2008). In this period, brain mice have morphological 
similarities to the third-trimester neonatal brains, in particular for what concerns 
cellular proliferation, cortical organization, synapse number, neurotransmitter 
synthetic enzymes and electrophysiology (Liu XH. et al., 1999). According to age and 
species, animals are subjected to different time intervals of hypoxia. It is well known 
that 150 minutes of hypoxia induces a severe damage in rats (Northington FJ. et al., 
2001; Jiang X. et al., 2008). In P7 mice 30 minutes of hypoxia may cause moderate 
injury while 1 hour causes a severe injury (Kendall GS. et al., 2006). As concern the 
regional distribution of brain damage, in rats, 48 hours after insult, necrotic and 
apoptotic cells are mainly localized in the ipsilateral cortex and striatum (Northington 
FJ. et al., 2001), while in mice the damage is restricted to ipsilateral hippocampus 
(Kendall GS. et al., 2006). 
 
 
1.2.2 CHRONIC AND INTERMITTENT HYPOXIA MODEL 
Cerebral palsy may develop in infants with chronic lung disease, correlated to 
premature birth or multiple hypoxic episodes. Some pathological features of 
developmental WMI can be reproduce through continuous or intermittent hypoxia in 
neonatal rodent models. In the model of chronic hypoxia, from postnatal days 3 to 
P13 or to P33, the rodents are placed with their dam in a hypoxic chamber in which 
the levels concentration of O2 are continuously monitored. Hypoxia was maintained 
at 9.5 ± 1.0% O2, the air continuously diffused within the chamber, and excess carbon 
dioxide and humidity are filtered. Twice weekly the chamber was opened for less 
than 5 minutes, then the water and food are changed (Ment LR. et al., 1998; Back 
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SA. et al., 2006; Chahboune H. et al., 2009; Scafidi J. et al., 2009). It has been 
demonstrated that mice subjected to chronic perinatal hypoxia showed long-term 
neurobehavioral deficits (Chahboune H. et al., 2009), ventriculomegaly and 
hypomyelination. The ventriculomegaly is a consequence of the loss of cerebral 
tissue, while the hypomyelination is correlated to reduction of early OL progenitors 
(Back SA. et al., 2006). 
In the model of intermittent hypoxia, from postnatal days 2 or 3 (P2 or P3) for 28 
days, the mice are exposed to alternating cycles of 2 min of 6.0–7.5% O2 followed by 
3 min of normoxia, which were generated by balances of 100% N2 and 100% O2 
gases (Douglas RM. et al., 2003). CO2 levels and humidity were maintained near 
physiological levels. This cycle is replicated during daylight hours for all experimental 
period (Douglas RM. et al., 2003). It has been demonstrated that the exposition of 
intermittent hypoxia caused a significant neuronal injury in the hippocampus and 
thalamus (Douglas RM. et al., 2007). Thus, chronic and intermittent hypoxia 
determine a different altered genes responsible for cell signaling, development, 
metabolism and cell death (Zhou D. et al., 2008).  
 
 
1.2.3 INTRAUTERINE HYPOXIA ISCHEMIA MODEL 
Intrauterine models of transient global ischemia have been described in the rat 
and rabbit by housing pregnant dams in hypoxic conditions or by the abruption of 
placental blood flow by inflation of a balloon catheter inserted into the uterine artery, 
respectively (Cai Z. et al., 1995; Hersey K. et al., 1995; Cai Z. et al., 1998). This 
model reproduces many histopathological aspects of developmental WMI (Derrick M. 
et al., 2007). In rabbits, the lesions involve the cerebral gray and white matter, in 
some cases, there is an intraventricular hemorrhage with ventriculomegaly and 
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periventricular white matter loss. In addition, the surviving rabbit kits show a wide 
range of hypertonic motor deficits that resemble CP. This model allows to analyze 
the clinical-pathological correlations with neurobehavioral outcomes and 
neuroradiological assessments (Drobyshevsky A. et al., 2005). Moreover, intrauterine 
hypoxia ischemia model has also been extensively used to study the cellular 
mechanisms of WMI (Buser JR. et al., 2010). 
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1.3 PRECONDITIONING  
The brain is constantly subjected to influence of intrinsic and extrinsic stimuli. 
During stressful and pathological conditions brain is able to activate endogenous 
neuroprotective strategies able to preserve its integrity. Among these neuroprotective 
strategies, preconditioning has been widely studied in the last decades for its 
potential therapeutic implications. Preconditioning (PC) represents a subliminal 
injurious stimulus applied before a longer harmful ischemia (Kirino T., 2002; Dirnagl 
U. et al., 2003; Gidday JM., 2006) is able to exert a remarkable neuroprotection, thus 
establishing a state of tolerance to anoxic conditions (Pignataro G. et al., 2012). The 
toxicologist Paracelsus studied for the first time this phenomenon during the 16th 
century. He observed that low levels of cellular stress induced the activation of a 
protective response, as is summarized from one of his important mentions: “The dose 
makes the poison” (Stetler RA. et al., 2014). PC as phenomenon protective strategy 
applicable to different organs. In fact, in 1986 Murry et al., observed that intermittent 
brief ischemia followed by reperfusion protects the myocardium from acute ischemic 
episodes (Murry CE. et al., 1986). Currently, PC is being largely studied in brain 
ischemia, however, several researchers are examining this phenomenon also in 
other neurodegenerative diseases, such as Parkinson‟s (Stetler RA. et al., 2014). It is 
well-known that PC protection can be activated into two different phases: “rapid or 
acute preconditioning” (Perez-Pinzon MA. et al., 1997). While “rapid preconditioning” 
starts 3–5 minutes after the preconditioning stimulus and ends 1 hour later; “delayed 
preconditioning” (Perez-Pinzon MA. et al., 1997), begins 2–3 days after 
preconditioning and ends 1 week later (Dirnagl U. et al., 2003). Rapid preconditioning 
induces a transient and less strong neuroprotection than delayed preconditioning, in 
addition, it is not associated with de novo protein synthesis (Barone FC., et al., 1998; 
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Dirnagl U. et al., 2003). Conversely, delayed preconditioning is associated with 
longer molecular changes (Durukan A. and Tatlisumak T, 2010), as the neosynthesis 
of heat shock protein 72, the induction of transcription factors, and the activation of 
anti-apoptotic proteins (B-cell lymphoma 2) (Brambrink AM. et al., 2000) and 
antioxidant enzymes (Toyoda T. et al., 1997). The effects of preconditioning stimuli 
have been studied through in vitro and in vivo models of stroke, demonstrating that 
they induced anti-apoptotic mechanisms with consequent survival of tissue after 
acute ischemia, mainly through the activation of PI3K/AKT signaling pathway 
(Hausenloy DJ. et al., 2006). Ischemic preconditioning (IPC) triggers the synthesis of 
antioxidant molecules, such as MnSOD, through activation of a specific pathway. At 
first time, it induces the reduction of ATP synthesis and promotes the activation of 
mitochondrial ion channels, such as the mitochondrial ATP-sensitive K+ (mitoKATP) 
channel (Otani H. 2004; Sart S. et al., 2014). This event determines a mild ROS 
release, which triggers the activation of protein kinase C, the activation of nuclear 
factor kappa beta and finally the synthesis of MnSOD (Otani H. 2004; Sart S. et al., 
2014). Therefore, IPC treatment protects neurons and non-neuronal tissues, 
furthermore, it reduces infarct volume at least 33% in IPC if compared with non-IPC 
treated controls (Schaller B. and Graf R., 2002). 
 
 
1.3.1 HYPERBARIC OXYGEN PRECONDITIONING AND NEONATAL 
HYPOXIA ISCHEMIA 
Hyperbaric oxygen (HBO) is a condition obtained through infusion of 100% O2 
flow in a pressurized chamber. This state may protect the brain from following focal 
and global ischemia. In fact, it has been demonstrated, in gerbil and in rat, that the 
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exposition to 2-2.5 pressures of atmosphere absolute (ATA) every day for 3 or 5 
sessions induced tolerance against global ischemia (Wada K. et al., 1996, Cheng O. 
et al., 2011). In adult rats, subjected to middle cerebral artery occlusion (MCAO), it 
has been demonstrated that the exposition to 2.5 ATA for 1 hour per days for 5 days 
until 24 hours before induction of insult, protected brain against global or focal 
cerebral ischemia (Ostrowski RP. et al., 2008). In contrast, in the same vivo model, it 
has been demonstrated that the exposition to 2.5 ATA for 1 hour at 24, 12, 6 hours 
before induction of insult, the preconditioning induce less protective effects 
(Ostrowski RP. et al., 2008). In HI model it has been proven that the exposition to 2.5 
ATA for 2.5 h, followed to HI insult 24 h later, protects immature brain (Freiberger JJ. 
et al., 2006; Li Z. et al., 2008b).  
 
 
1.3.2 HYPOTHERMIA AND HYPERTHERMIA PRECONDITIONING IN 
NEONATAL HYPOXIA ISCHEMIA 
Currently, the therapeutic hypothermia is considered the first accepted 
treatment in neonatal HIE disease (Walsh BH. et al., 2011). In fact, in some clinical 
trials, HI full-term newborns are subjected to hypothermia, that is considered the gold 
standard method to protect the immature brain. In addition, it has been demonstrated 
that the hypothermia can represent a preconditioning stimulus. In particular, in adult 
rats subjected to twenty minutes of hypothermia (31–32°C), and following subjected 
to focal ischemia it has been proved that the hypothermia induced a delayed 
preconditioning, with the effect beginning 6 h after preconditioning and persisting for 
2 days after (Nishio S. et al., 1999; Nishio S. et al., 2000). In vitro model of ischemia 
have been observed that 20‟ of hypothermia (33°C), before OGD reduces Purkinje 
cell death in rat cerebellar slices (Yuan HB. et al., 2004; Yuan HB. et al., 2006).  
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Recently, it has been also reported that hyperthermia is able to act as a 
preconditioning stimulus in vitro and in vivo models. In particular, it has been proved 
that hyperthermic preconditioning prevents disruption of blood–brain barrier, in this 
way it has been analyzed the reduction of damage in newborn rat subjected to HIE 
insult (Tomoaki I. et al., 1999). In adult rats it has been well established that the 
exposition of animals for 15 min in a water bath set at 42°C, before MCAO, reduced 
infarct volume 18 or 24 h later injury (Xu H. et al., 2002) and improved learning 
abilities and memory following diffuse axonal injury (Su Z. et al., 2009). About HI 
model, there are few evidences on the protective role of hyperthermic 
preconditioning.  
 
 
1.3.3 PHARMACOLOGICAL PRECONDITIONING IN NEONATAL HYPOXIA 
ISCHEMIA 
The neuroprotective effect of different drugs used as preconditioning agents 
has been evaluated in several studies. In particular, it has been characterized the 
neuroprotective effect of the inhalation of anesthetics like sevoflurane and isoflurane, 
in adult and neonatal cerebral ischemia (Kitano H. et al., 2007; Li L. and Zuo Z., 
2009; McAuliffe JJ. et al., 2007; Zhao P. et al., 2007; Zhao P. and Zuo Z., 2004; 
Zheng S. and Zuo Z., 2004; Zhu W. et al., 2010). In 2012, Yang et al. reported that 
the effects of sevoflurane preconditioning in mice subjected, 5 days before MCAO, to 
2.5% sevoflurane for 1 hours everyday and sacrificed 72 hours after ischemia 
induction. The results showed that there was a reduction of brain damage and 
improved of neurobehavioral performance in preconditioned mice compared to 
control mice. In this study, they suggested that the effects of sevoflurane 
preconditioning can be mediated by activation of canonical Notch signaling pathway. 
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In particular, their results demonstrated that the sevoflurane preconditioning 
increased of Notch intracellular domain (NICD) protein that then travels to the 
nucleus to associate with the DNA-binding protein (RBP-J) (Yang Z. et al., 2012). 
These events determined that activation of proteins involved in different physiological 
pathways, including proliferation, differentiation processes (Kopan R et al., 2009; 
Andersson ER. et al., 2011) and proteins involved in neuroprotective mechanisms 
(Yang Z. et al., 2012). In vivo model of HI, it has been demonstrated that the 
exposition to 1% or 2% of isoflurane 15 minutes and 24 hours before the HI insult 
protects the brain of P7 pups (Sasaoka N. et al., 2009), and improves later functional 
outcomes in adult mice (McAuliffe JJ. et al., 2007; Zhao P. et al., 2007). 
 
 
1.3.4 HYPOXIC PRECONDITIONING IN NEONATAL HYPOXIA ISCHEMIA 
Hypoxic preconditioning (HPC) stimulus triggers a rapid state of tolerance and 
has a limited time frame, of approximately 72 hours (Bernaudin M. et al., 2002; Prass 
K. et al., 2003; Zhan L. et al., 2010; Stetler RA. et al., 2014). Hypoxic preconditioning 
has been studied in vitro and in the neonatal and adult in vivo model. The stimulus is 
reproduced in hypoxia chamber, where oxygen is replaced by nitrogen, typically to 
normobaric hypoxic conditions (8% oxygen). In the neonatal rats (P6–7) subjected to 
hypoxia (8% O2; 92% N2) in a humidified chamber held at 37°C, then followed by 
normoxia for 24 hours, and then pathological HI, it has been demonstrated that 
hypoxia triggers preconditioned state (Gidday JM. et al., 1994; Ota A. et al., 1998). 
Neural and behavioral outcomes are improved in preconditioning group compared to 
non-preconditioned groups, for an extended time period (Gustavsson M. et al., 2005). 
In 2013, Ara et al. evaluated the neural stem progenitors (NSPs) proliferation, 
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differentiation and neurogenesis in SVZ of newborn piglets subjected to 3 hours of 
hypoxic preconditioning, 24 hours before severe hypoxia ischemia. These 
researchers demonstrated that PC induced proliferation of endogenous NSPs up to 7 
days after the hypoxic–ischemic injury. NSPs derived from SVZ of newborn 
preconditioned piglets formed a greater number of neurospheres, generated twice of 
neurons and astrocytes in vitro (Ara J. et al., 2013). In 2014, Suryana et al. analyzed 
in rat pups (P6) subjected to 3 hours of hypoxia and subsequent to HI, 24 hours later, 
the effect of maturation of the oligodendrocyte lineage cells. They demonstrated that 
hypoxic preconditioning prevented the loss of myelin binding protein (MBP) staining 
caused by HI, and they suggested that potentially mild hypoxia could be used to 
protect or reverse the maturational arrest of pre-OLs in conditions of myelination 
process alteration (Suryana E. et al. 2014). 
Hypoxic preconditioning might have an age-dependent evolution, in fact, this 
protection was not observed in slices, derived from aged animals (>2 years of age) 
and subjected to severe OGD (Bickler PE. et al., 2010; Stetler RA. et al., 2014). 
These results suggest that the mature brain is more susceptible to oxidative injury 
(Xu K. et al., 2007; Stetler RA. et al., 2014), and has less capacity to repair itself after 
sublethal or lethal insult (Mattson MP. et al., 2002; Stetler RA. et al., 2014). 
Interestingly, in human pluripotent stem cells (PSCs) it has been demonstrated that 
hypoxic preconditioning and oxidative stress induces anti-apoptotic mechanisms 
through the stabilization of HIF-2α, which inhibits p53 and increased Bcl-2 expression 
(Das B. et al., 2012; Sart S. et al., 2014). While, in mesenchymal stem cells (MSCs) 
cultured hypoxic preconditioning supports HIF-1α stabilization, which is normally 
degraded by HIF prolyl-4-hydroxylases in normoxia conditions (Muscari C. et al. 
2013, Sart S. et al., 2014) (Fig. 1). HIF-1α regulates the activity of glycolytic enzymes 
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and inhibits the pyruvate dehydrogenase, these events induce the shift of metabolic 
from oxidative phosphorylation to glycolysis, producing ROS decrease (Sart S. et al., 
2014). So HIF-1α is a necessary component of the protective mechanisms involved 
in HPC. In fact, in HIF-1α knockout mice, subjected to hypoxic-ischemic injury, the 
damage is more severe than wild-type HI mice and HPC is not able to protect HIF-1α 
from severe hypoxia ischemia (Sheldon RA. et al., 2014). 
Also in vivo model of IPC it has been demonstrated that this stimulus enhanced to 
neurogenesis in the dentate gyrus. In fact, LEE et al. studied the neuroprotective 
mechanisms of IPC and examined whether neurogenesis and angiogenesis 
increased following severe ischemia in rats subjected to IPC pretreatment. Their 
results demonstrated that 10 minutes of IPC treatment induced to cell proliferation in 
SVZ, with a peak of cell proliferation 7 days after IPC treatment. The proliferated cells 
differentiated into mature neurons within 14 days to IPC stimulus (Lee SH. et al., 
2007). In according with previous studies (Stagliano NE. et al., 1999; Dirnagl U. et 
al., 2003) LEE et al. observed about 30% reduction of infarct volume and an 
improvement of functional outcome, which persisted for 28 days, after subsequent 
prolonged focal ischemia (PFI). Therefore, authors identified the increase of 
angiogenesis in the ischemic penumbra after PFI suggesting that repair mechanisms 
of endogenous neurogenesis involved the replacement of lost neurons; the release of 
trophic substances, and self-regeneration (Picard-Riera N. et al., 2004).  
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Figure 1. Molecular mechanisms involved in the neuroprotection mediated by 
preconditioning in stem cells (Sart S. et al., 2014). 
Different stimuli are able to induce the expression of anti-apoptotic molecules and trophic 
factors (Heat shock treatment, chronic oxidative stress exposition; chronic hypoxia 
exposition). Chronic exposition to hypoxia inhibits the degradation of hypoxia-inducible factor 
(HIF)-1a, mediated by prolyl-hydroxylase through ubiquitination. The stabilization of HIF-1a 
reduces oxidative phosphorylation, determining the opening of mitoKATP channels and the 
activation of protein kinase C (PKC) (Sart S. et al., 2014). PKC activates nuclear factor 
kappa beta (NFkβ) signaling, that induces the expression of antioxidant proteins (MnSOD) 
and anti-apoptotic proteins (Bcl-2) (Sart S. et al., 2014). In addition, chronic hypoxia induces 
the transcription of neurotrophic factors (VEGF, FGF, BDNF) (Sart S. et al., 2014).  
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1.4 NEUROGENESIS    
The CNS is composed of different cell lines: neurons, oligodendrocytes, 
astrocytes, and non-neural cell types. Neurons are the main effector cells of the 
CNS, they are involved in the mechanisms of elaboration and transport of information 
entering and leaving the CNS. Oligodendrocytes determine the myelination of related 
axons, which induces to the rapid propagation of action potentials through neurons 
(Maldonado-Soto AR. et al., 2014). The astrocytes have a role of support of the CNS, 
as they regulate the traffic of molecules, which pass from blood to the brain. In 
addition, they are involved in the cellular phagocytosis and maintaining of brain 
homeostasis (Barres BA. et al., 2008; Molofsky AV. et al., 2012; Maldonado-Soto AR. 
et al., 2014). During embryonic life, until birth, the cerebral cells are formed by the 
same pool of stem cells: radial glial cells (Kriegstein A. et al., 2009; Maldonado-Soto 
AR. et al., 2014). The stem cells are unspecialized cells, characterized by high 
proliferative potential and are able to renew themselves through cellular division, for 
indefinite periods, generating specialized cell types which constitute the various 
tissue and organs. Stem cells can be distinguished into two different types, in 
according to the stage of development and differentiate potential: Embryonic stem 
cells (ESCs) and Adult stem cells (ASCs). ESCs are pluripotent cells, they are able to 
renew themselves and generate all the different cell types of organism, in appropriate 
conditions. ESCs come from an embryo at the blastocyst stage, then 4-5 days after 
fertilization. Adult stem cells are multipotent undifferentiated cells, they maintain the 
homeostasis of tissue in which they are found and are involved in repairing the tissue 
after a damage. In the mid-1960s Altman and Das identified proliferating cells in the 
mature rat brain (Altman J. and Das GD.,1965; Altman J. and Das GD.,1966; 
Maldonado-Soto AR. et al., 2014). Subsequently, the development of proliferation 
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markers, such as [3H]-thymidine or 5-bromo-20-deoxy-uridine (BrdU), which labels 
DNA during the S-phase, confirmed the presence of proliferating cells in the mature 
mammalian brain (Maldonado-Soto AR. et al., 2014). The neural stem cells (NSCs) 
have self-renewal and pluripotent capacity, they generate the three neural cell 
phenotypes. Therefore, neurogenesis is a multi-step process characterized by 
different phases: proliferation; differentiation; migration; and synaptic integration of 
new neurons in the local neural circuit. During specific time-frames of adult 
neurogenesis, these cells can be distinguished morphologically by using specific 
markers. In the adult mammalian brain, NSCs are localized into two regions, called 
niches, characterized by specialized microenvironments that support their self-
renewal and differentiation throughout their life. In the ventricular–subventricular zone 
(V/SVZ) of the lateral ventricles (LV) the new olfactory bulb neurons are continuously 
generated, they are functionally integrated into neural circuits. In the same way, in 
the subgranular zone (SGZ) of the dentate gyrus (DG) the new granule cells are 
generated (Vargas VS. et al., 2013). In both niches, the NSCs have features of 
astrocytes, with radial-like morphology and exhibit hallmark ultra-structural (Pastrana 
E. et al., 2011; Vargas VS. et al., 2013). 
 
 
1.4.1 NEUROGENESIS IN VENTRICULAR–SUBVENTRICULAR ZONE 
The V/SVZ is a major germinal area in the adult mammalian brain, it is 
characterized by a thin layer of dividing cells adjacent to the lateral walls of the LV. In 
1997, Doetsch F. and her colleagues established the ultrastructural and 
immunocytochemical features of cell types in the adult rodent SVZ. The V/SVZ is 
composed of three main layers (ependymal layer, neuroblast network and 
perivascular layer) (Vargas VS. et al., 2013). Ependymal layer is composed of multi-
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ciliated ependymal cells (E1) and bi-ciliated ependymal cells (E2), which are 
arranged as a series of pinwheels (Mirzadeh Z. et al., 2008; Vargas VS. et al., 2013). 
Their nuclei are spherical, the chromatin is not clumpy, and in their apical cytoplasm 
there are many mitochondria and basal bodies (Doetsch F. et al., 1997). The 
neuroblasts are neuron precursors, they have an elongated cell body with one or two 
processes, a cytoplasm containing many free ribosomes, a small Golgi apparatus, a 
few short cisternae of rough endoplasmic reticulum (RER), and many microtubules 
oriented along the long axis of the cells. Their nuclei have an abundant lax chromatin 
with two to four small nucleoli, the nuclei may be invaginated (Doetsch F. et al., 
1997). The neuroblasts are connected with the other cells through small junctional 
complexes, which are distributed over the cell surface and contain endocytic 
vesicles. These compartments may be exchange sites of signals. The neuroblasts 
are organized as a network of chains throughout the SVZ (Doetsch F. et al., 1996; 
Vargas VS. et al., 2013). Along the entire length of SVZ extends a planar venous 
plexus (Shen Q. et al., 2008; Tavazoie M. et al., 2008; Vargas VS. et al., 2013). In 
addition, the V-SVZ niche is characterized by many populations of astrocytes, that 
have different morphologies and locations (Pastrana E. et al., 2011; Vargas VS. et 
al., 2013). The stem cells radial glial-like (Type B) express astroglial markers, such 
as glial fibrillary acidic protein (GFAP) (Donega V. et al., 2013). There are two 
subtypes of these cells, type B1 and B2, which have a different cytoplasm, chromatin 
and distribution compared with ependymal cells. These cells are quiescent in vivo 
and can be activated by specific signals in physiological conditions, such as 
pregnancy, and pathological states, as seizures (Scharfman HE. et al., 2009) stroke 
(Yoo SW. et al., 2008) or hypoxia ischemia (Kadam SD. et al., 2008). They divide 
themselves and give rise to active proliferating cells (Type C). These cells are large, 
55 
 
more spherical with a few processes, their nuclei contained deep invaginations and 
mostly lax chromatin (Doetsch F. et al., 1996). They are characterized by a large 
Golgi apparatus, a few ribosomes, and some small junctional complexes (Doetsch F. 
et al., 1996). Type C cells, through the intermediate transit amplification, generate 
neuroblasts (Type A), then the immature neurons migrate far from the olfactory bulb 
(Pastrana E. et al., 2011; Vargas VS. et al., 2013). Finally, these neurons 
differentiate into olfactory GABAergic granule interneurons, glutamatergic 
juxtaglomerular neurons or dopaminergic periglomerular interneurons, and integrate 
into the local neuronal circuits (Carleton A. et al., 2003; Brill MS. et al., 2009; Braun 
SM. and Jessberger S., 2014). The B1 stem cells are highly polarized cells, which 
interact with the cerebrospinal fluid (CSF) and the center of pinwheels through a 
small apical process. Furthermore, they interact through their soma with the 
intermediate SVZ and through long basal process with vasculature via (Vargas VS. et 
al., 2013) (Fig.2). SVZ is connected with CSF, which fills the ventricles and is 
primarily produced by a mini-organ floating in the ventricles, choroid plexus. In the 
CSF/ependymal compartment the cell–cell interactions occur and CSF composition 
influences V/SVZ stem cells and their progeny. CSF, during the embryo life, 
promotes the proliferation of neural progenitors, through the release of IGF2. While in 
adult CSF, there are many growing factors and ligands involved in V-SVZ stem cell 
life such as SHH, Wnts, TGFs, IGFs, PDGFs, BMPs, Slits and retinoic acid (Lehtinen 
MK. et al., 2011; Marques F. et al., 2011; Lee C. et al., 2012; Vargas VS. et al., 
2013). In addition, there are extracellular matrix fragments and exosomes, that may 
contain factors regulating the proliferation and the differentiation of stem cells 
(Marzesco AM. et al., 2005; Street JM. et al., 2012; Vargas VS. et al., 2013). 
Furthermore, it is well known that the rostral flow of the CSF establishes the vectorial 
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gradients, that may contribute to regulate the directional migration of neuroblasts 
(Sawamoto K. et al., 2006; Vargas VS. et al., 2013). 
Then, B1 stem cells receive signals from three niche compartments: the 
CSF/ependymal cell niche (apical), the intermediate SVZ niche and the perivascular 
niche (Fuentealba LC. et al., 2012; Vargas VS. et al., 2013) (Fig. 2).  
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Figure 2. Cell types in the V/SVZ niche (Vargas VS. et al., 2013).  
(a) The image shows the cells and compartments of adjacent area to the lateral ventricles 
(orange). The CSF/ependymal compartment is composed of the CSF, ependymal cells 
(multi-ciliated E1 cells and bi-ciliated E2 cells, gray) and B1 stem cells (dark blue) that 
contact the ventricle, as well as axons (Vargas VS. et al., 2013). The intermediate SVZ niche 
is formed by B1 stem cells ( dark blue), transit amplifying Type C cells (green), and 
neuroblasts (Type A cells, red) (Vargas VS. et al., 2013). There are other cells: astrocytes 
(light blue), microglia (orange) and long distance axon terminals (purple). The perivascular 
niche is composed of blood vessels (pink), surrounded by pericytes (yellow) and astrocyte 
end feet (dark blue) (Vargas VS. et al., 2013). In addition, in this area there are macrophages 
and fibroblasts (dark gray). (b) B1 stem cells (green) are highly polarized cells, which interact 
through a long basal process with the blood vessels (red) (Vargas VS. et al., 2013). 
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1.4.2 NEUROGENESIS IN DENTATE GYRUS 
The subgranular zone is a tight layer of cells located between the granule cell 
layer (GCL) and hilus of the dentate gyrus. Also in the SGZ, the NSCs are in contact 
with blood vessel, differently from V-SVZ cells, they are not related with ventricular 
lumen. NSCs extend their radial processes into the molecular layer (ML), through the 
GCL (Bonaguidi MA. et al., 2011; Encinas JM. et al., 2011; Braun SM. and 
Jessberger S., 2014), and generate, through a short-lived intermediate progenitor, 
the new neurons (Fig. 3). These cells migrate far from the GCL, within 3 weeks, then, 
the new granule cells project out a large dendritic arbour into the ML and an axon 
into the hilus (van Praag H. et al., 2002; Zhao C. et al., 2006; Toni N. et al., 2007; 
Toni N. et al., 2008; Braun SM. and Jessberger S., 2014). In this way, they integrate 
into the local circuit (Vargas V.S. et al., 2013). In the adult SGZ there are two types of 
stem cells (Type I and Type II) (Fukuda S. et al., 2003; Steiner B. et al., 2006). The 
Type I progenitors are radial glial-like cells, they express both marker GFAP and 
Nestin compared to the other astrocytes of SGZ. Indeed, the astrocytes express 
GFAP marker only (Seki T. et al., 1993; Donega V. et al., 2013). The Nestin is an 
intermediate filament protein Type VI (IFN), it is expressed by astrocytes and radial 
glial cells during the brain development. It starts to disappear from postnatal day 
eleven in the rat cortex (Kalman M. and Ajtai BM., 2001; von Bohlen O. und Halbach, 
2007), therefore, it is downregulated and is replaced by intermediate filament 
proteins, as neurofilaments. In the early stages of neurogenesis there is a balance 
between quiescence and proliferation of NSPCs. Many intrinsic and extrinsic cellular 
factors, regulating this balance, have been identified, including Notch signaling 
(Ables JL. et al., 2010; Ehm O. et al., 2010; Lugert S. et al., 2010), Wnt signalling (Lie 
DC. et al., 2005, von Bohlen O. und Halbach, 2007), Sox2 transcriptional activity 
(Favaro R. et al., 2009; Suh HK. et al., 2007; von Bohlen O. und Halbach, 2007), and 
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lipid metabolic processes (von Bohlen O. und Halbach, 2007; Knobloch M. et al., 
2013). From Type I cells derive the Type II progenitors (Type D cells) (Fukuda S. et 
al., 2003; Steiner B. et al., 2006), that divide themselves and give rise the immature 
neurons. These cells are characterized by the expression of two specific proteins: 
doublecortin (DCX) and poly-sialylated neural adhesion molecule (PSA-NCAM) 
(Donega V. et al., 2013). Doublecortin is a protein involved in the microtubule 
polymerization, it is expressed in neuroblasts and newborns neurons (Gleeson JG. et 
al. 1999; Francis F. et al. 1999; von Bohlen O. und Halbach, 2007). PSANCAM is a 
membrane-bound glycoprotein, which belongs to the class of neural cell adhesion 
molecule (NCAM) (Nacher J. et al., 2002). It is characterized by a long chain of 
polysialic acid, which gives anti-adhesive properties to the molecules (Rutishauser 
U., 1996). PSANCAM is involved in cell migration (Ono K. et al., 1994; Rutishauser 
U., 1996), axonal growth and fasciculation (Doherty P. et al., 1990 ; Zhang H. et al., 
1992; Nacher J. et al., 2002), and synaptic reorganization (Miller PD. et al., 1994; 
Seki T. et al., 1996; Nacher J. et al., 2002). Finally, the immature neurons become 
newborn neurons, that are characterized by specific expression of neuronal nuclei 
marker (NeuN) (Donega V. et al., 2013). 
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Figure 3. Cell types in the Dentate Gyrus niche (Alvarez-Buyalla A. et al., 2002). 
The image shows the cells and architecture of the subgranular layer (SGL). SGL astrocytes 
(B cells) are characterized by long radial processes that penetrate the granule cell layer and 
short tangential ones that run parallel to SGL (Alvarez-Buyalla A. et al., 2002). B cells are 
able to divide themselves and generate immature dark cells (D cells), which mature into new 
granule neurons (G cells) (Alvarez-Buyalla A. et al., 2002). 
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1.4.3 NEUROGENESIS ACTIVATION IN HYPOXIC-ISCHEMIC INSULT  
There are several studies about the endogenous ability of the neonatal brain 
to regenerate itself after hypoxic-ischemic insult and the molecular mechanisms 
involved in this process. In 2004, Plane et al. studied the proliferation of neural stem 
cells in neonatal SVZ mice, after moderate HI insult. In particular, mice were 
subjected to ischemia and 45‟ hypoxia (P10) and sacrificed at different time intervals 
(P18, P24, P31). The authors observed the increase of neural progenitors in SVZ 
and in peri-infarct striatum after HI insult (Plane JM. et al., 2004). In 2007, Yang et al. 
analyzed the differentiation and migration of SVZ progenitors in mice subjected to HI 
(P6) and monitored from 2 weeks to 5 months of recovery after insult. This study 
demonstrated that SVZ precursors divided themselves and generated neocortical 
neurons. In addition, they observed the presence of new cells that colonized cell-
sparse columns, composed of reactive astrocytes. This result confirmed a previous 
Luzzati‟s study, in which he showed the presence of chains of migrating cells in the 
SVZ, these cells were connected with the mature brain parenchyma (Luzzati F. et al., 
2003). Yang verified that the neurogenesis process was induced by the production of 
insulin-like growth factor-1 and monocyte chemoattractant factor-1 (Yang Z. et al., 
2007). Therefore, the proliferation of neural progenitor cells can be induced by 
growing factors. Im SH. et al. verified that a continuous intracerebroventricular 
administration of low dose BDNF and EGF stimulated striatal neurogenesis in 
hypoxic-ischemic mice. In particular, they showed that the increase of BrdU+/III-
tubulin+ (marker of proliferating cells) in SVZ mice after 2 weeks of treatment, and the 
migration of neuroblasts in the SVZ and the ventricular side of neostriatum mice, 8 
weeks after chronic infusion. The new striatal neurons were identified with 
BrdU+/NeuN+ immunostaining. These effects determined an improvement of motor 
functions in mice, that were analyzed through Rotarod test (Im SH. et al., 2010). In 
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2010, Lòpez and his colleagues demonstrated the remyelination of the injured 
external capsule and the increase of the number of both NG2+ types of cells (a 
marker of early oligodendrocyte progenitors) in HI rats treatment with cannabinoid 
drug, WIN55212-2, from postnatal days 7 to P14. In particular, in SVZ this drug 
enhanced cell proliferation and oligodendrogenesis through induction of the 
transcriptional factor Olig2. This factor activated the differentiation of stem cells 
characterized by OL phenotype. Moreover, WIN55212-2 induced white matter 
remyelination and generation of neuroblast cells in the injured striatum 1 week after 
HI induction (Lòpez DF. et al., 2010). In 2014, Codega et al. identified and isolated 
quiescent adult NSCs from neurogenic niche. In particular, they performed in vivo 
and in vitro analyses to determine the expression profiling of these cells. In ZSV of 
mice they identified quiescent and activated populations of stem cell astrocytes and 
their cell cycle properties by using immunohistochemical analyses with specific 
combination of markers (CD133, GFAP, and EGFR). In addition, they analyzed 
functional behaviour, in vivo, and gene expression profiles of qNSCs and aNSCs in 
vitro (Codega P. et al., 2014). Similarly to SVZ, also in the hippocampus there is 
evidence of neurogenesis activation after HI injury. Kadam and his colleagues used a 
mouse model of neonatal stroke to characterize the long-term effects of 
neurogenesis. They focused their attention on the identification of the newborn cells 
originated from SGZ and migrated in the ipsilateral and contralateral DG, and 
newborn cells derived from SVZ and migrated in the ipsilateral and contralateral 
striatum and neocortex. Then, hypoxic-ischemic mice were subjected to 5 
intraperitoneal administration of BrdU, 1 weeks later insult. The analyses of 
immunohistochemistry were performed on mice (P40) in order to monitor the 
neuronal and glial cell-lineage markers and BrdU incorporation. These analyses 
63 
 
revealed that the cell-lineage commitment expressed the features similar to controls 
of 1 week after injury. At P40, the total number of new neurons, derived from SGZ, 
was reduced in ipsilateral and contralateral hippocampus, while the cells, derived 
from SVZ, were amplified (Kadam SD. et al., 2008). 
Qiu et al. analyzed the effects of HI injury on proliferation and differentiation of neural 
stem cells in the immature (P9) and juvenile (P21) mouse hippocampus. At first, 
C57BI/6 mice were subjected to HI insult, after they were subjected to administration 
of bromodeoxyuridine (50 mg/kg) daily for 7 days after insult. Finally, 5 weeks later, 
BrdU cells were quantified in DG and CA areas. They observed that the juvenile 
brain showed a major increase of BrdU labeling than the immature brain after insult. 
Then, in dentate gyrus the proliferation of NSCs significantly increased in the juvenile 
brain compared to immature brain, but the total number of BrdU+ cells was less in 
control juvenile brains than control immature brains. The authors explain this result 
reporting that during the first phase of physiological development of brain the 
proliferation and neurogenic abilities are more and decrease with age. Instead, in 
physiological conditions the juvenile brains had low levels of NSCs proliferation, thus, 
the damage induced the proliferation in the juvenile brains. In addition, they observed 
a strong inflammatory response in the juvenile hippocampus, which was correlated 
with the increase of the proinflammatory cytokine levels (MCP-1, IL-18) and an 
increase of microglia proliferation 3 days after HI induction.  
These divergence results may be correlated with the differences severity of the insult 
and susceptibility to damage of CD-1 mice compared to C57Bl/6 mice. In addition, in 
Kadam‟s study the analysis of BrdU labeling was performed in a period of full 
development of DG, while in Qiu „s project the cells were detected in the early phase 
of DG development (Donega V. et al., 2013). 
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Currently, the long-term survival effects of newborn neuronal cells are not also clear, 
indeed, it is not known whether these new cells integrate into the local circuitry and 
evolve into functional cells in the no fully developed brain (Donega V. et al., 2013). 
Some studies in rodents model of neonatal HI showed that few new neurons survived 
6 months after insult (Nakatomi H. et al., 2002; Miles DK. and Kernie SG., 2008; 
Donega V. et al., 2013), and they had reduced electrophysiological properties (Seri 
B. et al., 2004; Donega V. et al., 2013).  
Nowadays, there are a great number of studies on the fate of newborn cells, 
originated from SVZ and migrated in cortex, striatum, after HI injury. These studies 
showed: a significant increase of glial cell-fate commitment in these areas, the 
differentiation of striatal neuron committed cells in cholinergic neurons or 
parvalbumin (PV), calbindin (CB), or somatostatin (SOM) interneuron subtypes; and 
the differentiation of cortical BrdU+ cells into calretinin (CR) interneurons (Yang Z. et 
al., 2007; Yang Z. et al., 2008; Donega V. et al., 2013). In cortex the major number of 
interneurons were of the PV subtype. These results suggest that the NSCs originated 
from the SVZ may differentiate into CR interneurons (Donega V. et al., 2013) . 
 
 
1.4.4 MOLECULAR AND CELLULAR MECHANISMS INVOLVED IN 
REGULATION OF NEUROGENESIS IN HYPOXIC-ISCHEMIC BRAIN 
Neurogenesis process is not fully understood, in spite of several studies. It is 
well known that the neurovascular niche has an important role in the regulation, 
proliferation, differentiation, and survival of newborn cells. Astrocytes are connected 
to proliferating cells and to blood vessels in DG and produce different factors that are 
involved in neurogenic processes (Palmer TD. et al., 2000; Song H. et al., 2002; 
Shen Q. et al., 2004; Donega V. et al., 2013). Growth factors and neurotrophins, 
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such as Brain-derived neurotrophic factor (BDNF); VEGF; and morphogens as Wnt3; 
Shh; Noggin regulate cell proliferation and differentiation. The wnt proteins are 
glycoproteins that act as molecule signals in many cellular processes. They are 
involved in three different molecular mechanisms: the canonical pathway Wnt/β-
catenin; and not canonical pathways of Wnt/JNK and Wnt/Ca2+ (Budnik V. et al., 
2011). Wnt has an important role in the development of CNS (Ciani L. et al., 2005). 
Recent evidences suggest that wnt signal may modulate excitatory and inhibitory 
synaptic transmission (Budnik V. et al., 2011). Wnt-7a increases the synaptic 
transmission and determines the increase of neurotransmitter release in cerebellar 
and hippocampal synaptic, through not canonical dependent Camk II pathway. These 
results suggest that the wnt signal mechanisms may have an essential role in 
modulation of synaptic plasticity and cellular development. Shh proteins are involved 
in neuronal cell-fate commitment, while Noggin in neuronal cell differentiation (Zhao 
C. et al., 2008; Donega V. et al., 2013). Recent data established the crucial 
regulatory role of membrane receptors Notch1 in distinct phase of neurogenesis after 
hypoxic-ischemic brain injury (Felling RJ. et al., 2006; Donega V. et al., 2013). Gene 
expression analyses revealed that overexpression of the intracellular portion of 
Notch1 enhanced the proliferation of stem cells GFAP+ (Schroeter EH. et al., 1998; 
Donega V. et al., 2013). In contrast, the ablation of Notch1 expression determined a 
decrease of proliferating cells with astrocytic phenotype and induced the increase of 
neuron differentiation in ZSG (Breunig JJ. et al., 2007; Donega V. et al., 2013). Then, 
the expression of Notch1 influenced the regenerative capacity of NSCs, and itself 
may be regulated by other molecules as gp130, a membrane receptor involved in 
survival and proliferation of NSCs (Chojnacki A. et al., 2003; Donega V. et al., 2013). 
As Notch, after hypoxic-ischemic event the ablation of Fibroblast growth factor 
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receptor 1 (FGFR1) reduced the proliferation of stem cells GFAP+ in ZSV  and 
compromised cortical pyramidal neuron development (Fagel DM. et al., 2009; 
Donega V. et al., 2013). In 2006, Felling et al. analyzed the mRNA levels of series 
membranes receptor (Notch1; EGFR; gp130) and observed their increase and a 
major proliferation of NSCs in the ipsilateral SVZ at 48 hours after insult (Felling RJ. 
et al., 2006; Donega V. et al., 2013). The interaction of EGFR and its ligands, as 
EGF1 and TGFa, activated MAPK and Rac pathways, that are implicated in all phase 
of neurogenesis process (Yarden Y. et al., 2001; Donega V. et al., 2013). 
Also, the neurotransmitters seem to be implicated in the regulation of neurogenic 
process in immature brain after injury. In fact, it has been demonstrated that synapse 
formation may be regulated by GABAergic innervations, the glutamatergic 
innervations are involved in neuroblasts survival; dendritic development; and 
synaptogenesis, while Dopaminergic signaling promoted the proliferation (Pathania 
M. et al., 2010; Donega V. et al., 2013). Lee S-R et al. studied the role of matrix 
metalloproteinases (MMPs), a family of zinc endopeptidases, in neuroblast migration 
through axonal extension (Maddahi A. et al., 2009; Donega V. et al., 2013). Their 
results established that the migration of neuroblasts into striatum are suppressed 
with MMPs inhibition (Maddahi A. et al., 2009; Donega V. et al., 2013). In the 
hippocampus the migration of neuroblasts from SGZ to DG are regulated by radial 
glial fibers; very -low-density lipoprotein receptor (VLDLR); and apolipoprotein E type 
2 receptor (ApoER2) (Tissir F. et al., 2003; Donega V. et al., 2013); and an 
extracellular matrix serine protease that interrupted migrating neurons signals 
(D‟Arcangelo G. et al., 1995; Donega V. et al., 2013). 
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1.5 SODIUM/CALCIUM EXCHANGER (NCX) 
The Na+/Ca2+ exchanger (NCX) is an important transmembrane protein 
involved in the regulation of Ca2+ and Na+ homeostasis in neuronal cells and in 
various cell types. NCX is a member of Ca2+ cation antiporter superfamily (CaCA), it 
catalyzes the exchange of three Na+ ions and two Ca2+ ions across the plasma 
membrane (Fujioka Y. et al, 2000; Kang TM. and Hilgemann DW., 2004; Reeves JP. 
and Hale CC., 1984). In mammalian brain there are three dominant genes coding for 
three isoforms: NCX1 (Nicoll DA. et al, 1990), NCX2 (Li Z. et al, 1994), and NCX3 
(Nicoll DA.et al, 1996) proteins. In 1996 Nicoll et al, identified NCX genes localization 
by mapping mouse chromosomes. NCX1; NCX2; NCX3 are respectively localized on 
17, 7, and 12, chromosomes (Nicoll DA. et al, 1996). Currently, more than 15 splice 
of NCX1 are known (Kofuji P. et al. 1994; Quednau BD. et al. 1997), these variants 
have a tissue-specific distribution and exchange properties that fulfill the tissue 
requirements (Quednau BD. et al., 1997). It has been found one NCX2 alternative 
splicing (Quednau BD. et al., 1997), and three variants for NCX3. The NCX3 gene is 
composed of 9 exons (Quednau BD. et al., 1997), the exons 2 and 3, also named A 
and B, respectively, are mutually exclusive (Quednau BD. et al., 1997). Exon 4, also 
known exon C, is optional. In the rat was observed that the exon A and C are found 
in skeletal muscle (NCX3-AC), while the exon B is expressed in the brain (NCX3-B 
and NCX3-BC). The transcription of NCX1 genes is tissue-specific and is 
independent on intracellular calcium levels (Lee SL et al., 1994; Annunziato L. et al., 
2009). Brain NCX1 promoter is characterized by several consensus sequences for 
specific protein 1 (Sp-1), three binding sites for activator protein 2 (AP-2); putative 
binding sites for nuclear factor kB (NFkB) and HIF-1 (Annunziato L. et al., 2009). 
NCX3 genes promoter contains a repressor sequence constituted by a double of 
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downstream regulatory element (DRE) (Annunziato L. et al., 2009). The specific 
transcriptional factor called transcription of Ca2+- modulated transcriptional repressor 
downstream regulatory element antagonist modulator (DREAM), binding to this 
sequence (Annunziato L. et al., 2009). When the intracellular levels of calcium is 
high, DREAM is not able to link DRE, then an increase of NCX3 transcription occurs 
(Gomez-Villafuertes R. et al., 2005; Annunziato L. et al., 2009). Therefore, NCX3 
genes transcription depends on calcium intracellular levels (Annunziato L. et al., 
2009). Also NCX2 genes transcription depends on calcium intracellular levels 
(Annunziato L. et al., 2009). All NCX isoforms are constituted of 10 transmembrane 
(TM) domains (John SA. et al. 2013; Szerencsei RT.et al. 2013), arranged in two 
clusters separated by a large intracellular loop of 500 residues (Fig. 4). In 2012, Liao 
et al. analyzed the crystal structure of prokaryotic Methanococcus jannaschii 
(NCX_Mj), and confirmed the presence of 10 TM segments arranged around a tightly 
packed core region, in which there are four cation-binding sites. The transmembrane 
segments can be distinguished into an N-terminal hydrophobic domain and into a C-
terminal hydrophobic domain, that are linked through a large hydrophilic intracellular 
loop of 550 amino acids, named the f-loop (Nicoll DA. et al, 1999). The f-loop is not 
implicated in Na+ and Ca2+ translocation, but it regulates NCX activity.  
The NCX1 is an ubiquitously protein expressed in brain, heart, skeletal muscle, 
smooth muscle, kidney, eye, secretory, and blood cells, whereas NCX2 isoform is 
expressed only in brain and NCX3 protein is expressed only in brain and skeletal 
muscle (Lee SL. et al., 1994; Annunziato L. et al., 2009). In addition, NCX1 and 
NCX3 have a different localization in brain and neuronal cells (Quednau BD. et al., 
1997; Yu SP. and Colvin DW., 1997; Annunziato L. et al., 2009). 
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Figure 4. Structure of Na+/Ca2+ exchanger 3 (NCX3). (Secondo A. et al., 2015) 
The protein is composed of 10 TM segments arranged around a tightly packed core region, 
in which there are four cation-binding sites. 
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1.5.1 REGULATION OF SODIUM/CALCIUM EXCHANGER  
The activity of the sodium/calcium exchanger is regulated by different factors: 
(I) the concentration of the two cations transported, Na+ and Ca2+; (II) the intracellular 
pH; (III) cytoplasmic messengers and transductional mechanisms, 
phosphatidylinositol 4,5 bisphosphate (PIP2), protein kinase C (PKC) and protein 
kinase A (PKA), (IV) reactive oxygen species, reactive nitrogen species (RNS), 
glutathione reduced (GSH), and glutathione oxidized (GSSG) (Annunziato L. et al., 
2004). The concentration of calcium regulates NCX through CBD (Ca2+-binding 
domain). NCX activity is blocked by the removal of intracellular Ca2+ (Nicoll DA. et al., 
1999; Hilge M. et al., 2006; Annunziato L. et al., 2009). In the same way, the increase 
of sodium concentration blocks NCX activity (Annunziato L. et al., 2009). The 
exchanger activity is also regulated by the intracellular pH. In particular, also the little 
reductions in pH, as a value of 0.4, can induce an inhibition of NCX of 90% 
(Annunziato L. et al., 2009). The ATP is able to increase the activity of the exchanger 
in different ways (Annunziato L. et al., 2009). First, by activating G protein-coupled 
receptors for endogenous and exogenous ligands second, ATP can stimulate the 
activity of NCX through the pathway involving PKC or PKA (Annunziato L. et al., 
2009). Finally, NCX can be activated by the production of lipid PIP2. This lipid binds 
the XIP region of the loop "f" which eliminates the inactivation of NCX, thus 
stimulating the function exchanger (Nicoll DA. et al., 1999; Hilge M. et al., 2006; 
Annunziato L. et al., 2009). Interestingly, the depletion of ATP determines the 
inactivation of NCX1 and NCX2 but has no effect on activity of NCX3 (Secondo A. et 
al, 2007).  
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1.5.2 PHYSIOLOGICAL ROLE OF SODIUM/CALCIUM EXCHANGER  
The Na+/Ca2+ exchanger protein is involved in several neurophysiological 
processes. Depending on the intracellular concentrations of Ca2+, [Ca2+]i, and Na+, 
[Na+]i, NCX can work in two modes: in forward mode four or three Na+ ions enter 
cytoplasm and one Ca2+ ion exits from the cytoplasm; in reverse mode Na+ ions exit 
and Ca2+ ion enters. In neurons, NCX is mainly expressed at the level of synapses 
(Juhaszova M. et al., 1996; Canitano A. et al., 2002; Annunziato L. et al., 2009). 
During the increase of action potential Ca2+ ions enter plasma membrane, this event 
induces the fusion of synaptic vesicles with the plasma membrane and promotes the 
neurotransmission. Then, K currents repolarize the plasma membrane and Ca2+ ions 
are distributed in the cytosolic compartment, but the residual of Ca2+ ions is extruded 
by the plasma membrane Ca2+/ATPase and by NCX (Annunziato L. et al., 2009).  
 
 
1.5.3 SODIUM/CALCIUM EXCHANGER ROLE IN ISCHEMIC STROKE  
It is well known that NCX isoforms are involved in several pathological 
conditions, mediating a neuroprotective effect. It has been demonstrated that NCX 
has an important role in stroke pathogenesis. In 2004, Pignataro et al. analyzed the 
role of NCX isoforms in brain damaged, after ischemia induction. In particular, they 
examined the expression of NCX isoforms in different areas and evaluated the 
measure of brain infarct volume in adult rats in which the focal ischemia was 
reproduced by using pMCAO technique. The authors performed these analyses also 
in pMCAO rats in which the NCX gene was silenced by using antisense 
oligodeoxynucleotides (AS-ODNs) (Pignataro G. et al., 2004). The researchers 
demonstrated that there was a significant decrease of NCX1, NCX2, and NCX3 from 
6 to 72 hours after pMCAO in ischemic core, in contrast in penumbra area there was 
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only the reduction of NCX3 isoform (Pignataro G. et al., 2004). In addition, they 
proved that the silencing of NCX1 and NCX3 isoforms determined the increase of 
damage and worsening of deficits (Pignataro G. et al., 2004). In 2006, Boscia et al. 
confirmed that NCX expression is regulated in a differential manner after pMCAO, 
and there was a different expression of NCX isoforms in regions involved in the 
insult. Also in 2004, Pignataro et al. analyzed the effects of pharmacological inhibition 
or activation of NCX in brain rats subjected to pMCAO. In particular, they examined 
the effects of following drugs: the glutamate exchange inhibitory peptide (GLU-XIP), 
the exchange inhibitory peptide (XIP), diarylaminopropylamine derivative bepridil, the 
isothiourea derivative (KB-R7943), ferric chloride (FeCl3), and the amiloride derivative 
5-(N-4-chlorobenzyl)-20,40-dimethylbenzamil (CB-DMB) (Pignataro G. et al., 2004). 
They demonstrated that the inhibitors of NCX (GLU-XIP, KB-R7943, and bepridil) 
determined a significant increase of brain damage in rat subjected to pMCAO 
compared to control, in contrast, XIP did not cause the rise of infarct volume in rats 
(Pignataro G. et al., 2004). About KB-R7943, they reported that drug inhibited the 
NCX in the reverse mode of operation (Pignataro G. et al., 2004). In addition, they 
confirmed that the administration of FeCl3 functioned as NCX activator and reduced 
the brain infarct volume in ischemic rats, as Amoroso et al. had already reported in 
anoxia conditions (Amoroso S. et al., 1997; Pignataro G. et al., 2004). Nevertheless, 
the authors established that FeCl3 activity had been neutralized by the 
coadministration of KB-R7943 (Pignataro G. et al., 2004). In 2007, Tortiglione et al. 
analyzed the different sensitivity to NCX in neuron subtypes of peri-infarct area, after 
the pharmacological inhibition of protein in rat slices subjected to pMCAO. The 
researchers demonstrated that the activation of NCX maintained ionic homeostasis in 
the peri-infarct area after focal ischemia (Tortiglione A. et al., 2007). In particular, 
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they observed that the administration of bepridil and CB-DMB caused an irreversible 
electrophysiological alteration of NCX activity in peri-infarct area, related to field 
potential amplitude (Tortiglione A. et al., 2007). Then, the authors suggested that the 
inhibition of NCX could trigger a cascade of events leading to neuronal damage 
(Tortiglione A. et al., 2007). In 2008, Molinaro et al. studied the role of NCX3 protein 
during severe anoxia condition. In particular, they evaluated the effects of ncx3 
ablation on neuronal survival, organotypic hippocampal cultures and primary cortical 
neurons from ncx3-/- mice were subjected to oxygen glucose deprivation (OGD) plus 
reoxygenation. In this study, the authors demonstrated that infarct volume increased 
in the ncx3 knocking-out mice subjected to t-MCAO compared to control and there 
was a significant increase in cell death of ncx3 knocking-out cortical neurons 
subjected to OGD. In addition, they showed that hippocampal subregions CA1, CA3, 
and DG of ncx3 knocking-out had a major vulnerability to anoxia condition (Molinaro 
P. et al, 2008). Therefore, these results suggested that NCX3 was able to maintain 
intracellular levels of calcium and protect neurons during hypoxia condition. These 
data confirmed the results of Secondo‟s study, in which it has been demonstrated 
that BHK cells transfected with the brain specific NCX3 gene, unlike NCX1 and 
NCX2 transfected cells, are able to maintain [Ca2+]i homeostasis during hypoxia plus 
reoxygenation-induced by Ca2+ overload, although ATP concentrations are reduced. 
NCX worked in the forward mode of operation in the presence of reduced levels of 
ATP (Secondo A. et al, 2007). Furthermore, the silencing of NCX1 or NCX3 induced 
a major vulnerability to chemical hypoxia in BHK cells (Secondo A. et al, 2007). In a 
recent paper published by Pignataro et al, it has been shown that NCX1 and NCX3 
represent a new molecular effector involved in a neuroprotective mechanism called 
“ischemic preconditioning” (Pignataro G. et al, 2012). In particular, they analyzed the 
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brain infarct volume and the expression of NCX isoforms in rats subjected to 
preconditioning stimulus (30 min of tMCAO) 72 h before 100 min of tMCAO 
(Pignataro G. et al, 2012). The results showed that there was a significant reduction 
of infarct volume in preconditioned rats subjected to harmful ischemia and the 
ischemic preconditioning induced NCX1 and NCX3 overexpression in ipsilateral 
temporoparietal cortex of preconditioned rats compared to group subjected alone 
tMCAO (Pignataro G. et al, 2012). In addition, they demonstrated that the silencing of 
NCX1 and NCX3 genes prevented the neuroprotective effects mediated by ischemic 
preconditioning (Pignataro G. et al, 2012). In 2014, Sisalli et al. studied the effects of 
ischemic preconditioning on primary cortical neurons exposed to 30 minutes of OGD 
followed 24 hours after stimulus, to 3 hours OGD and reoxygenation for 24 hours. 
The authors demonstrated that IPC increased NCX1 and NCX3 protein expression 
48 hours after OGD plus reoxygenation induction and this effect was mediated by NO 
production and PI3K/Akt activation (Sisalli MJ. et al., 2014). Therefore, they 
established that IPC, mediated the upregulation of NCX1 and NCX3 activity, caused 
the endoplasmatic reticulum refilling and mitochondrial calcium extrusion, thus 
preventing intracellular calcium dysregulation induced by OGD (Sisalli MJ. et al., 
2014). In 2013, it has been developed a potent NCX activator, named neurounina-1. 
This new compound is 7-nitro-5-phenyl-1- (pyrrolidin-1-ylmethyl)-1H-
benzo[e][1,4]diazepin-2(3H)-one, the structure derived from modified structure of SM-
15811, a NCX inhibitors (Molinaro P. et al, 2013). In this work the authors analyzed 
the effects of Neurounina on NCX isoforms activity in the forward and reverse modes 
of operation by means of Ca2+ radiotracer, patch-clamp techniques, Fura-2 
microfluorimetry, and thereafter, with the help of chimera strategy, deletion, and site-
directed mutagenesis, it has been also identified the molecular determinants of this 
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compound on NCX structure (Molinaro P. et al, 2013). In addition, they evaluated the 
protective effects of Neurounina in vitro and in vivo model of ischemia (Molinaro P. et 
al, 2013). They demonstrated that Neurounina determined a potent and reversible 
stimulatory effect on NCX1 and NCX2 in both forward and reverse modes of 
operation, but it was not able to increase the activity of the NCX3 (Molinaro P. et al, 
2013). This compound is characterized by an high lipophilicity, therefore is able to 
pass blood-brain barrier in vivo. In mice subjected to tMCAO, it has been proved that 
the intraperitoneal administration of neurounina-1 in single doses ranging from 0.003 
to 30 mg/kg, 5 hours after ischemia induction, significantly reduced the infarct volume 
(Molinaro P. et al, 2013).  
In 2014, Vinciguerra et al. identified a family of microRNA, miRNA-103/107, is able to 
modulate NCX1 expression. They found that these microRNAs, by reducing NCX1 
expression, worsened ischemic damage induced by tMCAO. The researchers also 
proved that the administration of anti-miR-103-1 induced a selective upregulation of 
NCX1 protein expression, which mediated the neurological scores improvement in 
ischemic rats and a reduction of brain volume infarct (Vinciguerra A. et al., 2014). In 
2015, Secondo et al. reported the characterization of the newly synthesized 
compound 5-amino-N-butyl-2-(4-ethoxyphenoxy)-benzamide hydrochloride, named 
BED, as a new selective NCX3 inhibitor. (Secondo A. et al., 2015). They suggest that 
this compound may represent a useful element to distinguish the differential effects 
of NCX3 isoform in the diseases that require a tight control of Ca2+ homeostasis 
through NCX3 function (Secondo A. et al., 2015). 
 
76 
 
2 AIM OF THE STUDY 
This research project aims to characterize an experimental model of 
preconditioning in neonatal hypoxia ischemia, in order to identify new molecular 
targets potentially useful for the development of innovative short and long-term 
therapies in hypoxic-ischemic encephalopathy. Preconditioning is a phenomenon in 
which a subliminal injurious stimulus, applied before a longer harmful ischemia, is 
able to exert a remarkable neuroprotection, thus establishing a state of tolerance to 
anoxic conditions.  
In particular, the purposes of the present study were: (1) to identify preconditioning a 
reliable and valid stimulus; (2) to evaluate the time window in which the hypoxic 
preconditioning protected the ipsilateral hippocampus, in mice subjected to hypoxic-
ischemic damage. Once characterized a model of preconditioning, the purposes 
were: (3) to examine the proliferation and differentiation of neural stem cells, in 
hippocampus dentate gyrus and in subventricular zone of mice subjected to hypoxic 
preconditioning and/or severe hypoxic-ischemic injury. (4) To verify whether 
preconditioning stimulus improves the unconditioned reflexes in preconditioned 
hypoxic-ischemic mice compared with hypoxic-ischemic and finally, (5) to evaluate 
the relationship between the alteration of ionic homeostasis and the activation of 
endogenous neurogenesis mediated by plasma membrane NA+/Ca2+ exchange 
(NCX).  
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3 MATERIALS AND METHODS 
3.1 ANIMAL PROCEDURES 
Male and female mice C57BL/6 strains, housed under diurnal lighting 
conditions (12 h darkness/light) were used. All experimental animal protocols were 
approved by the University of Naples, Federico II. Animal Care and Use Committee 
and was performed with the highest standards of care under the National Institutes of 
Health guidelines. All efforts were made to minimize animal suffering and to reduce 
the number of animals used.  
 
 
3.2 STUDY DESIGN 
In order to accomplish the proposed objectives, the study has been divided 
into six phases: 
Phase 1. Ipsilateral hippocampal damage was evaluated in postnatal day 7 mice 
subjected to ischemia at different time intervals of hypoxia (10‟; 20‟; 30‟; 60‟) and 
sacrificed 24 hours after insult. The temporal course of Ipsilateral hippocampal 
damage was determined in P7 mice subjected to ischemia plus 60‟ hypoxia and 
sacrificed at different time intervals after insult (24 hours; 48 hours; 72 hours; 7 
days).  
 
Phase 2. The characterization of preconditioning stimulus was assessed in P7 mice 
subjected to different stimuli: 10‟ hypoxia; 20‟ hypoxia; 30‟ hypoxia; 60‟ hypoxia; 
ischemia; ischemia plus 10‟ hypoxia; ischemia plus 20‟ hypoxia. The animals were 
sacrificed 24 hours after insult. Then, immunohistochemical analyses were performed 
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on hippocampal mouse sections by using specific antibodies in order to evaluate the 
Nestin expression changes. 
 
Phase 3. It has been established the time window in which the hypoxic 
preconditioning protected the ipsilateral hippocampus of mice subjected to hypoxic-
ischemic injury (Fig. 5). The experimental groups were organized in three major 
groups and divided into two subgroups randomized as follows: 
Group 1. In the control subgroup, mice were subjected to HI 60‟ at P9 and sacrificed 
24 hours later. In the second subgroup, mice were subjected to 20‟ hypoxia (PC) at 
P7, following HI 60‟ at P9 and sacrificed 24 hours after insult; 
Group 2. In the control subgroup, mice were subjected to HI 60‟ at P10 and 
sacrificed 24 hours later. In the second subgroup, mice were subjected to 20‟ hypoxia 
(PC) at P7, following to HI 60‟ at P10 and sacrificed 24 hours after insult; 
Group 3. In the control subgroup, mice were subjected to HI 60‟ at P14 and 
sacrificed 24 hours later. In the second subgroup, mice were subjected to 20‟ hypoxia 
(PC) at P7, following to HI 60‟ at P14 and sacrificed 24 hours after insult. 
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Figure 5. Phase 3 experimental program. 
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Phase 4. The effects of hypoxic preconditioning on endogenous neurogenesis were 
examined in hippocampus dentate gyrus and in subventricular zone of mice 
subjected to hypoxic-ischemic injury. In particular, the differentiation of NSCs was 
followed through the analysis of proliferating BrdU+ cells. Then, immunohistochemical 
analyses were performed on hippocampal and striatum mouse sections by using 
specific antibodies. P7 mice were subjected to two intraperitoneal administrations of 
BrdU, with time frame of 90‟ minutes. Subsequently, the experimental groups were 
randomized as following (Fig. 6):  
Group 1. P7 naïve mice were subjected to two intraperitoneal administrations of 
BrdU and sacrificed at P11.  
Group 2. P7 mice were subjected to two intraperitoneal administrations of BrdU and 
20‟ hypoxia in the same day. At P10 they were subjected to HI 60‟ and sacrificed at 
P11.  
Group 3. P7 mice were subjected to two intraperitoneal administrations of BrdU. At 
P10 they were subjected to HI 60‟ and sacrificed at P11.  
 
          P0 P7 P10
HI 60’Animal birth
Preconditioning
20’ Hypoxia
P11
Sacrifice
BrdU 
administration
 
Figure 6. Phase 4 experimental program. 
 
Phase 5. It has been verified whether preconditioning stimulus could improve the 
unconditioned reflexes in preconditioned hypoxic-ischemic pups compared to 
hypoxic-ischemic pup mice. Then, mice were monitored with several behavioral tests 
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at different time intervals (Fig. 7). The experimental groups were randomized as 
follows:  
Group 1. Naïve pup group from postnatal day 7 to until the day of sacrifice (P11) for 
behavioral testing.  
Group 2. PC+HI pup group from postnatal day 7 to until the day of sacrifice (P11) for 
behavioral testing.  
Group 3. HI pup mice group from postnatal day 7 to until the day of sacrifice (P11) 
for behavioral testing. 
             P0 P7 P9 P10
HI 60’Animal birth
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20’ Hypoxia
P11
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Behavioral tests Behavioral tests
 
Figure 7. Phase 5 experimental program. 
 
Phase 6. It was evaluated the relationship between the alteration of ionic 
homeostasis and the activation of endogenous neurogenesis mediated by NCX. 
Protein expression analyses of NCX1 and NCX3 were performed in hippocampus 
mice. In addition, the cell count of NCX1+ and NCX3+ cells were performed in dentate 
gyrus mice. The experimental groups were randomized as following:  
Group 1. P11 naïve mice were sacrificed and tissues analyzed as previously 
described. 
Group 2. P11 preconditioned hypoxic-ischemic mice were sacrificed and tissues 
analyzed as previously described. 
Group 3. P11 hypoxic-ischemic mice were sacrificed and tissues analyzed as 
previously described. 
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3.3 HYPOXIC-ISCHEMIC SURGICAL PROCEDURE 
The ipsilateral ischemic injury has been induced in according to Rice-Vannucci 
model (Rice JE. et al., 1981; Vannucci SJ. et al., 2004). Postnatal day seven 
C57BL/6 mice were anesthetized with 1.5% sevoflurane, and 98.5% O2 (Oxygen 
concentrator, Mod. LFY-I-5). The body temperature of the animal was maintained at 
37±0.5°C during the whole procedure with a heating pad. Under a surgical stereo 
microscope, a midline skin incision (0.5 cm) was made on the neck, and the right 
common carotid artery (CCA) was exposed, and double ligated with a suture thread 
(6-0), in order to isolate the region respectively upstream and downstream of the 
area to be cut. CCA was cut between the two knots by using specific micro-clipper. 
The incision was rinsed with 1% lidocaine and sutured with a 6.0 polypropylene 
(Prolene) suture. The surgery involves a maximum duration of 10 minutes 
anesthesia. Animals were returned to their dams and monitored continuously during 
a recovery period of 1 hour. After that, the pups were subjected to different time 
intervals of hypoxia (10; 20; 30; 60 minutes). The hypoxic insult was reproduced by 
placing animals into a hypoxic chamber, perfused with an equilibrated gaseous 
mixture (8% O2 and 92% N2) which composition was monitored by using an Oxygen 
monitor. The hypoxic chamber was placed in a water bath heated to 37°C. At the end 
of the procedure, the pups were returned to their dams. The animals were monitored 
continuously for 30 minutes and then checked every 30 minutes for 2 hours and then 
daily until they were sacrificed, 24 hours; 48 hours; 72 hours; 7 days after insult. 
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3.4 HYPOXIC PRECONDITIONING 
Postnatal day seven C57BL/6 mice were subjected to 20 minutes of hypoxia, 
into a hypoxic chamber, perfused with an equilibrated gaseous mixture (8% O2 and 
92% N2) monitored by using an Oxygen monitor. The hypoxic chamber was placed in 
a water bath heated to 37°C. Control pups not subjected to hypoxic preconditioning 
were exposed to room air in a chamber, which was placed in a water bath heated to 
37°C, for the same time intervals. At the end of the procedure, all pups were returned 
to their dams. The animals were monitored continuously for 30 minutes and then 
checked every 30 minutes for 2 hours and then daily until the induction of hypoxic-
ischemic injury. Following, the pups were subjected to HI, as previously described, at 
different time intervals (P9; P10; P14) and sacrificed 24 hours after insult.  
 
 
3.5 PROPIDIUM IODIDE LABELING, TISSUE PREPARATION AND 
BRAIN DAMAGE ANALYSIS 
Pup mice were anesthetized with 1.5% sevoflurane and 98.5% O2 gaseous 
mixture (Oxygen concentrator, Mod. LFY-I-5). The body temperature of the animal 
was maintained at 37°C during the whole procedure with a heating pad. Under a 
surgical stereo microscope, a midline sagittal skin incision (0.5 cm) was made on the 
skull. After identification of Bregma and Lambda coordinates, two microliters of 
Propidium Iodide (PI, 1 mg/mL in distilled water, Sigma) were injected into the right 
lateral brain ventricle of newborn mice. Twenty minutes after injection, pups were 
deeply anesthetized and transcardially perfused with saline solution containing 0.01 
ml heparin, followed by 10 ml of 4% paraformaldehyde in 0.1 mol/L PBS in saline 
solution. Brains were rapidly removed on ice and postfixed overnight at +4°C and 
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cryoprotected in 30% sucrose in 0.1 M phosphate buffer (PB) with 0.02% sodium 
azide for 24 hours at 4°C. The brains were cut on a cryostat into coronal sections 
(thickness 100 μm) in rostrum-caudal direction. Brain damage was assessed with 
Propidium Iodide technique, a method that detects degenerative cells (Carloni S. et 
al, 2007; Unal Cevik I. and Dalkara T., 2003). Propidium Iodide solution penetrates in 
the cells whose cellular membrane is damaged and allows to distinguish dark vital 
tissue from white necrotic and apoptotic tissue. Consecutive sections were analyzed 
with fluorescence microscope (Nikon E400) and acquired with software Image Pro-
Plus. The PI-stained infarct area was calculated with image analysis software 
(Image-J) (Bederson et al.,1986). Ischemic volume was obtained by the ratio 
between the sum of the infarction hippocampal areas of brain section and the sum of 
the total areas of the respective ipsilateral hippocampus, multiplied for thickness 
cerebral slides. The total infarct volume, corrected for edema, was expressed as 
percentage of the volume of the hippocampus ipsilateral to the lesion.  
 
 
3.6 TISSUE PROCESSING, IMMUNOSTAINING, AND CONFOCAL 
IMMUNOFLUORESCENCE  
Immunostaining and confocal immunofluorescence procedures were 
performed as previously described (Anzilotti S. et al., 2015). Pups were anesthetized 
and transcardially perfused with saline solution containing 0.01 ml heparin, followed 
by 10 ml of 4% paraformaldehyde in 0.1 mol/L PBS in saline solution. Brains were 
rapidly removed on ice and postfixed overnight at +4°C and cryoprotected in 30% 
sucrose in 0.1 M phosphate buffer (PB) with sodium azide 0.02% for 24h at 4°C. 
Next, they were sectioned frozen on a sliding cryostat at 40 μm thickness, in rostrum-
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caudal direction. Afterwards, free floating serial sections were incubated with PB 
Triton× 0.3% and blocking solution (0.5% milk, 10% FBS, 1% BSA) for 1 hours and 
30 minutes. So sections were incubated overnight at +4°C with following the primary 
antibodies: rabbit polyclonal anti-NeuN (1:1000, Millipore); mouse monoclonal anti-
Nestin (1:200, Millipore); rabbit polyclonal antibody glial anti-GFAP (1:500, Novus 
Biologicals). The next day, the primary antibodies were removed, sections were 
washed with 0.1 M phosphate buffer (PB) and incubated with the corresponding 
florescent-labeled secondary antibodies (Alexa 488/Alexa 594 conjugated 
antimouse/antirabbit IgGs). Nuclei were counterstained with Hoechst. Images were 
observed using a Zeiss LSM510 META/laser scanning confocal microscope (Zeiss, 
Oberkochen, Germany). Single images were taken with an optical thickness of 0.7 m 
and a resolution of 1024 × 1024. In double-labeled sections, the pattern of immune 
reactivity for both antigens was identical to that seen in single-stained material. 
Control double-immunofluorescence staining entailed the replacement of the primary 
antisera with normal serum (data not shown). To minimize a possible cross-reactivity 
between IgGs in double immunolabeling experiments, the full complement of 
secondary antibodies was maintained but the primary antisera were replaced with 
normal serum or only one primary antibody was applied (data not shown). In addition, 
the secondary antibodies were highly preadsorbed to the IgGs of numerous species. 
Tissue labeling without primary antibodies was also tested to exclude 
autofluorescence.  
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3.7 BrdU ADMINISTRATION AND IMMUNOHISTOCHEMISTRY 
For the acute BrdU labeling experiment, BrdU (Sigma, 100 mg/kg body weight, 
10 mg/ml in 0.007 N NaOH in 0.9% NaCl) was administered by intraperitoneal 
injection twice at postnatal day 7, with a time frame of 90 minutes. The dose (50µl) 
was administered in two times to facilitate absorption. Pups were subjected to 
hypoxic preconditioning and/or hypoxic-ischemic surgery, as previously described. At 
postnatal day 11, the mice were anesthetized and transcardially perfused, as earlier 
reported. The tissues were processed in according to protocol. Afterwards, free 
floating serial sections were incubated with 2M HCl for 30 minutes, following the 
sections were washed with 0.1 M PB, three times for 10 minutes. Then, the 
immunohistochemistry and confocal immunofluorescence was performed in 
according to procedure. It has been used the following primary antibodies: rat 
polyclonal anti-BrdU (1:300, Abcam); mouse monoclonal anti-PSANCAM (1:300, 
Millipore).  
 
 
3.8 DIAMINOBENZIDINE (DAB) IMMUNOSTAINING, AND CONFOCAL 
IMMUNOFLUORESCENCE  
Tissue processing was performed as previously described. Diaminobenzidine 
(DAB) immunostaining was performed with the Ultra Tek HRP kit (anti-polyvalent), in 
according to the manufacturer‟s protocol (Scy Tek Laboratories). 
Immunohistochemical staining protocol: (1) free floating serial slides were incubated 
in hydrogen peroxide for 15 minutes at temperature room; (2) they were washed 
twice for 10 minutes with 0.1 M phosphate buffer (PB); (3) sections were incubated in 
super block for 10 minutes at temperature room; (4) they were washed once for 10 
minutes with 0.1 M PB buffer; (5) tissues were incubated overnight at +4°C with 
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following primary antibodies: mouse monoclonal anti-NCX1 (1:500; Swant, 
Bellinzona, Switzerland), rabbit polyclonal anti-NCX3 (1:3000; Swant, Bellinzona, 
Switzerland). The next day, sections were washed four times for 5 minutes with 0.1 M 
PB buffer; (7) they were incubated with Ultra Tek Anti-Polyvalent for 10 minutes at 
room temperature; (8) sections were washed four times for 5 minutes with 0.1 M PB 
buffer; (9) sections were incubated with Ultra Tek HRP for 10 minutes at room 
temperature and rinsed four times in 0.1 M PB buffer; (10) under chemical hood, 
tissues were incubated with DAB Chromogen to DAB Substrate [120 µl] for 3 minute 
at room temperature; (11) DAB incubation was interrupted with pure water and 
sections were placed on polysine slides and stored in dark room overnight at room 
temperature; (12) slides were dehydrated with four passages in ethanol (50%; 70%; 
95%; 100%) for 5 minutes each one and by a single step in xylene for 10 minutes. 
Finally, slides were closed with Eukitt glue and cover glass. Images were observed 
using a Zeiss LSM510 META/laser scanning confocal microscope (Zeiss, 
Oberkochen, Germany). Single images were taken with an optical thickness of 0.7 
mm and a resolution of 1024 × 1024. 
 
 
3.9 INTENSITY OF NESTIN IMMUNOSTAINING 
The double-labeled tissue (Fig. 10, 12) was used to evaluate the fluorescence 
intensity of Nestin in hippocampus dentate gyrus. The consecutive and identical 
sections were selected starting from bregma −1.46 mm, interaural +2.34 in order to 
analyze the dentate gyrus. During the phase of image acquisition by confocal 
microscope, standard conditions were regulated (Pinhole 35 µm; Laser intensity 6.6 
Units; Dimensions (x512, y512); Image size 1277.25 µm; Digital offest 0; Digital gain 
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1; Master gain 678). One image for each section was acquired. Three-four sections 
were analyzed for each mouse. Image J software was used to measure the 
fluorescence intensity of Nestin (Anzilotti S. et al., 2012).  
 
 
3.10 CELL-COUNTING ANALYSIS 
The number of BrdU and PSANCAM positive cells was determined in the 
dentate gyrus of the hippocampus and subventricular zone of C57BL/6 mice at 
postnatal day 11, by manual counting at × 10 magnification. The consecutive and 
identical sections were selected starting from bregma −1.46 mm, interaural +2.34 in 
order to analyze the dentate gyrus. While the consecutive and identical sections were 
selected starting from bregma 0.14 mm, interaural +3.94 for the analysis of 
subventricular zone. Only BrdU and PSANCAM positive cells with clearly visible cell 
bodies and profiles were counted. Six mice per group were included in the study of 
dentate gyrus, and four slices for each mouse were analyzed. Five mice per group 
were included in the study of subventricular zone, and three-four slices for each 
mouse were analyzed. 
The number of NCX1 and NCX3 positive cells was determined in the dentate gyrus 
of the hippocampus of C57BL/6 mice at postnatal day 11, by manual counting at × 10 
magnification. The consecutive and identical sections were selected starting from 
bregma −1.46 mm, interaural +2.34. Only NCX1 and NCX3 positive cells with clearly 
visible cell bodies and profiles were counted. Three mice per group were included in 
the study, and four slices for each mouse were analyzed (Anzilotti S. et al., 2015).  
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3.11 WESTERN-BLOT ANALYSIS  
Western-blot analyses were performed in according to protocol of Pignataro‟ s 
study (Pignataro G. et al., 2012). Hippocampal samples were harvested from brains 
of mice subjected to (a) hypoxic preconditioning plus HI, (b) HI, and (c) control. Under 
all the experimental conditions, ten groups of ipsilateral and contralateral 
hippocampal slices were obtained after 24 hours of hypoxic-ischemic injury for 
analysis of NCX1 protein, while for NCX3 analyses 6 groups of ipsilateral and 
contralateral hippocampal slices were obtained. Mouse brain samples were 
homogenized in a lysis buffer (0.5 M Hepes ph 7.4, 1 M NaF, 100 Mm Na3O4V; 1 M 
Naazide, 25% Triton X-100) containing protease and the phosphatase inhibitor. After 
centrifugation at 11,000 g at 4 °C for 30 minutes, the supernatants were collected. 
Protein concentration was estimated using the Bradford reagent. Then, 50 μg of 
protein was mixed with a Laemmli 4x sample buffer. The samples were resolved by 
8% sodium-dodecyl-sulfate polyacrylamide gel electrophoresis and transferred to 
nitrocellulose membranes. Blots were probed with antibodies anti-NCX1 (mouse 
monoclonal; Swant, Bellinzona, Switzerland; 1:1000 dilution), anti-NCX3 (rabbit 
polyclonal; Swant, Bellinzona, Switzerland; 1:2000), and anti-β-Tubulin (Sigma-
Aldrich mouse monoclonal 1:10000 dilution). After, nitrocellulose membranes were 
first washed with 0.1% Tween 20 and then incubated with the corresponding 
secondary antibodies for 1 hour (GE Healthcare, Little Chalfont, UK). 
Immunoreactive bands were detected with the ECL (GE Healthcare). The optical 
density of the bands (normalized with β-Tubulin) was determined by Chemi-Doc 
Imaging System (Bio-Rad, Segrate, Italy) 
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3.12 BEHAVIORAL TESTS 
Experiments were performed under diurnal lighting conditions between 10:00 
A.M. and 5:00 P.M. Pups mice were analyzed in behavioral reflex tests in according 
to Ten protocol (Ten VS. et al., 2003). Reflex tests were performed at different time 
intervals: (1) twice at postnatal day 7; (2) at postnatal day 9; (3) at postnatal day 11, 
before sacrifice. 
 
 
3.12.1 RIGHTING REFLEX TEST 
In according to Ten‟s protocol mice were placed in a supine position, and the 
time (in seconds) required to flip to the prone position was measured (Ten VS. et al., 
2003). It has been given to each pup three attempts with a maximum time of 30 
seconds for each trial, the mean time to perform the reflex was written down. The 
analyses were performed in control group (n=12), hypoxic-ischemic group (n=11) and 
preconditioned hypoxic-ischemic group (n=11). 
 
 
3.12.2 CLIFF AVOIDANCE REFLEX TEST 
In according to Ten‟s protocol pups were placed with their forepaws and chest 
extending over the board of table tend to move away by backing up with forepaws or 
their body and head turning sideways (Ten VS. et al., 2003; Fan LW. et al., 2010). In 
according to Fan, it has been considered the time required (in seconds) to come 
back from the edge was recorded, but it has been chosen up to a maximum 
observation time of 30 seconds; if the mouse was unable to perform the reflex within 
the allotted time or fell off from the table, the maximal time was assigned (Ten VS. et 
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al., 2003; Fan LW. et al., 2010). Each pup was given three attempts with a maximum 
time of 30 seconds for each trial, the mean time to perform the reflex was written 
down. The analyses were performed in control group (n=12), hypoxic-ischemic group 
(n=13) and preconditioned hypoxic-ischemic group (n=13). 
 
 
3.12.3 GEOTAXIS REFLEX TEST  
In according to Ten‟s protocol, pups were placed head downward on an 
inclined board (40◦) (Ten VS. et al., 2003). In according to Ten, it has been 
considered the time (in seconds) required for the pups to rotate their bodies head up 
(>90◦rotation) was recorded, but it has been chosen up to a maximum observation 
time of 30 seconds; if the mouse was unable to perform the reflex within the allotted 
time or fell off from the table, the maximal time was assigned. Each pup was given 
three attempts with a maximum time of 30 seconds for each trial, the mean time to 
perform the reflex was written down. The analyses were performed in control group 
(n=12), hypoxic-ischemic group (n=14) and preconditioned hypoxic-ischemic group 
(n=14). 
 
 
3.13 STATISTICAL ANALYSIS  
The data were evaluated as mean ± S.E.M. Statistically significant differences among 
means were determined by ANOVA followed by Newman-Keuls post-hoc test. For 
the comparison between the percentage of hippocampal damage in preconditioned 
hypoxic-ischemic and hypoxic-ischemic mice statistically significant differences 
between means were determined by t-Test. Statistical significance was accepted at 
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the 95% confidence level (p<0.05). Statistical analyses were performed by using 
GraphPad Prism 5 software and graphs with Microsoft Excel.  
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4 RESULTS  
 
4.1 EFFECT OF ISCHEMIA AND DIFFERENT DURATION OF 
HYPOXIA (HI) ON HIPPOCAMPAL DAMAGE EVAULATED 24 HOURS 
AFTER INJURY 
The damage was evaluated through Propidium Iodide administration in vivo, in 
four groups of animals (P7), subjected to several time intervals of hypoxia (10'; 20'; 
30'; 60') following ischemia induction. Hippocampal damage significantly increased 
according to the duration of hypoxia (Fig. 8). The damage was localized in the 
ipsilateral hippocampus to the CCA, mainly in CA1 and CA3 areas. 
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Figure 8. (A) The image shows the area analyzed for each brain slice in hypoxic-ischemic 
mice. (B) The hippocampal damage significantly increases in HI 60‟ mice compared to HI 10‟ 
group, 24 hours after induction of insult. Each column represents the mean ± S.E.M of data 
obtained from ischemic brain volume analysis of seven-day-old mice subjected to ischemia 
and to several time intervals of hypoxia (10, 20, 30, 60 minutes). The total infarct volume, 
corrected for edema, was expressed as percentage of the volume of the hippocampus 
ipsilateral to the lesion. *P<0.05 versus HI 10‟ group. The analyses were performed in seven 
mice for each group. 
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4.2 TIME COURSE OF HIPPOCAMPAL DAMAGE INDUCED BY 
ISCHEMIA AND HYPOXIA 60’ (HI)  
The evolution of ipsilateral hippocampal damage was evaluated through 
Propidium Iodide administration in vivo, in four groups of animals (P7) subjected to 
ischemia plus 60‟ hypoxia and sacrificed at different time intervals after insult (24h; 
48h; 72h; 7 days). Hippocampal damage significantly increased 7 days after 
induction of insult, with a mean value of 42.5%. The damage was localized in CA1 
and CA3 hippocampal areas as confirmed by immunofluorescence analyses (Fig. 9).  
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Figure 9. (A) Representative images of Propidium Iodide staining in the hypoxic-ischemic 
groups have been shown. Scale bar 100 µm. (B) The hippocampal damage significantly 
increases in HI 60‟ mice 7 days after induction. Each column represents the mean ± S.E.M of 
data obtained from ischemic brain volume analysis of seven-day-old mice subjected to 
ischemia plus 60‟ hypoxia and sacrificed at different time intervals (24 hours, 48 hours, 72 
hours, 7 days). The total brain infarct volume, corrected for edema, was expressed as 
percentage of the volume of the hippocampus ipsilateral to the lesion. *P<0.05 versus HI 60‟ 
plus 24 hours of reperfusion. The analyses were performed in the following groups: HI 60‟ 
and 24h reperfusion (n=7), HI 60‟ and 48h reperfusion (n=5), HI 60‟ and 72h reperfusion 
(n=5), HI 60‟ and 7 days reperfusion (n=5). 
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4.3 FLUORESCENCE INTENSITY OF NEURAL STEM CELL (NSC) 
MARKER, NESTIN, INCREASES AFTER 20’ OF HYPOXIA 
FOLLOWED BY 24 HOURS OF RECOVERY 
In order to analyze the activation of NSCs in dentate gyrus niche, after a 
specific stimulus, fluorescence analysis was performed in different mice groups. Pup 
mice (P7) were divided into the following eight groups: control, ischemia, 10‟ hypoxia, 
20‟ hypoxia, 30‟ hypoxia, 60‟ hypoxia, ischemia plus 10‟ hypoxia, ischemia plus 20‟ 
hypoxia. All mice were sacrificed 24 hours after stimulus induction. The fluorescence 
analysis was performed through immunohistochemistry by using specific antibodies: 
anti-NeuN, anti-Nestin, and marker of nuclei Hoechst. NeuN antibody identifies the 
mature neurons, while Nestin antibody allows to identify an intermediate filament 
protein type VI (IFN), that is a component of neural progenitor cytoskeleton. Then, 
anti-Nestin marks the NSCs localized in neurogenic niches. The analysis of Nestin 
fluorescence intensity showed that there was a significant increase of Nestin in mice 
group subjected to 20‟ hypoxia compared to control group. In addition, there was a 
significant reduction of Nestin in mice groups subjected to 30‟ and 60‟ hypoxia 
compared to control and 20‟ hypoxic groups (Fig. 10, 11). Furthermore, the analysis 
of Nestin showed that there was not a significant change in mice subjected to a 
stronger insult (Fig. 12, 13). 
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Figure 10. Distribution of Nestin and NeuN positive cells in mouse dentate gyrus. Single 
staining of Nestin (a-f); NeuN (g–l), Hoechst (m-r) in brain sections from control (a, g, m, 
respectively), ischemic (b, h, n, respectively), 10‟ hypoxic (c, i, o, respectively); 20‟ hypoxic 
(d, j, p, respectively); 30‟ hypoxic (e, k, q, respectively); 60‟ hypoxic (f, l, r, respectively) 
groups. Double-staining of Nestin and NeuN (s-t-u-v-z-w) in the dentate gyrus of six groups. 
Scale bar 200 μm. Standard conditions: Pinhole 35 µm; Laser intensity 6.6 Units; Dimensions 
(x512, y512); Image size 1277.25 µm; Digital offest 0; Digital gain 1; Master gain 678. 
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Figure 11. Fluorescence intensity of Nestin increases in mice subjected to 20‟ hypoxia 
compared to control mice. In addition, the fluorescence intensity of Nestin decreases in mice 
subjected to 30‟ and 60‟ hypoxia compared to control and 20‟ hypoxic groups. Each column 
represents the mean ± S.E.M of data obtained from measurements of fluorescent levels of 
Nestin in the dentate gyrus, for each mouse group (control, ischemia, 10‟ hypoxia, 20‟ 
hypoxia, 30‟ hypoxia, 60‟ hypoxia). Quantification of fluorescence intensity (expressed in 
arbitrary units, AU). *P<0.05 versus control group; #P<0.05 versus 20‟ hypoxic group. The 
analyses were performed in five mice for each treatment group, except 60‟ hypoxic mice 
group (n=4).  
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Figure 12. Distribution of Nestin and NeuN positive cells in the mouse dentate gyrus. Single 
staining of Nestin (a-d); NeuN (e-h), Hoechst (i-l) in brain sections from control (a, e, i, 
respectively), ischemic (b, f, j, respectively), HI 10‟ (c, g, k, respectively); HI 20‟ (d, h, l, 
respectively) groups. Double-staining of Nestin and NeuN (m-n-o-p) in the dentate gyrus of 
four groups. Scale bar 200 μm. Standard conditions: Pinhole 35 µm; Laser intensity 6.6 
Units; Dimensions (x512, y512); Image size 1277.25 µm; Digital offest 0; Digital gain 1; 
Master gain 678 . 
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Figure 13. Fluorescence intensity of Nestin does not increase in mice subjected to ischemia 
and ischemia plus hypoxia compared to control mice. Each column represents the mean ± 
S.E.M of data obtained from measurements of fluorescent levels of Nestin in the dentate 
gyrus for each mouse group (control, ischemia, ischemia plus 10‟ hypoxia, ischemia plus 20‟ 
hypoxia). Quantification of fluorescence intensity (expressed in arbitrary units, AU).The 
analyses were performed in control group (n=5), ischemic group (n=5), HI 10‟ group (n=3), HI 
20‟ group (n=4).  
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4.4 EVALUATION OF THE TIME WINDOW FOR HYPOXIC 
PRECONDITIONING NEUROPROTECTION  
The damage was evaluated through Propidium Iodide administration in vivo, in 
three major groups of animals (P7) in turn divided into two subgroups. The first group 
was subjected to hypoxic-ischemic insult at postnatal day nine (P9); the second 
group was subjected to hypoxic-ischemic insult at postnatal day ten (P10); the third 
group was subjected to hypoxic-ischemic insult at postnatal day fourteen (P14). In 
each group seven-day-old mice were divided into the first subgroup where the 
animals were untreated and in the second one the mice were subjected to hypoxic 
preconditioning, subsequently, both subgroups were subjected to HI insult at different 
time intervals (P9, P10, P14). All animals were sacrificed 24 hours after injury. The 
percentage of brain infarct volume has been valued for all subgroups. Then, the 
mean value of the first and second subgroup of each experimental condition was 
compared by using t-Test. Paired analysis demonstrated that there was a significant 
decrease of hippocampal damage in preconditioned mice, subjected to HI 60‟ three 
days after 20‟ hypoxia stimulus and sacrificed 24 hours later compared to mice 
subjected to only HI insult at P10 (Fig. 14). 
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Figure 14. (A) The image shows the area analyzed for each brain slice in hypoxic-ischemic 
and preconditioned hypoxic-ischemic mice (subjected to preconditioning at P7 plus HI 60‟ at 
P10). (B) The hippocampal damage significantly decreases in preconditioned hypoxic-
ischemic mice (P10) compared to hypoxic-ischemic mice (P10), sacrificed 24 hours after 
insult induction. Data represent the mean ± S.E.M. *P<0.05 versus CTRL (P7)+ HI 60‟ (P10). 
The analyses were performed in: CTRL (P7)+ HI 60‟ (P9) group (n=4), PC (P7)+ HI 60‟ (P9) 
group (n=7), CTRL (P7)+ HI 60‟ (P10) group (n=6), PC (P7)+ HI 60‟ (P10) group (n=7), CTRL 
(P7)+ HI 60‟ (P14) group (n=7), PC (P7)+ HI 60‟ (P14) group (n=11). 
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4.5 HYPOXIC PRECONDITIONING INCREASES THE TOTAL 
NUMBER OF PSANCAM POSITIVE CELLS IN SUBVENTRICULAR 
ZONE OF MICE SUBJECTED TO HYPOXIC-ISCHEMIC INJURY 
The effect of preconditioning stimulus (20‟ hypoxia) on endogenous 
neurogenesis was examined in subventricular zone of mice subjected to hypoxic-
ischemic injury. In particular, the differentiation of NSCs was monitored through the 
analysis of proliferating BrdU+ cells. As previously described, all P7 mice were 
subjected to two intraperitoneal administrations of BrdU, and eventually, they were 
divided into three experimental groups: control, hypoxic-ischemic; and preconditioned 
hypoxic-ischemic mice. Then, the analysis of proliferating NSCs was performed by 
using immunohistochemistry with specific antibodies: anti-BrdU, anti-PSANCAM, and 
marker of nuclei Hoechst. BrdU antibody identifies the proliferating cells, which have 
incorporated the BrdU dose, while PSANCAM antibody allows to identify a 
membrane-bound glycoprotein expressed by neuroblast cells. Then, double-staining 
of BrdU and PSANCAM marks the proliferating neural progenitors localized in 
neurogenic niches. The analysis of PSANCAM staining in subventricular zone 
showed that there was a significant increase of PSANCAM positive cells in 
preconditioned hypoxic-ischemic mice compared to hypoxic-ischemic group. In 
addition, the analysis of BrdU/PSANCAM double staining demonstrated that there 
was a significant decrease of BrdU/PSANCAM  positive cells in hypoxic-ischemic and 
preconditioned hypoxic-ischemic mice compared to control group (Fig. 15, 16).  
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Figure 15. Distribution of PSANCAM and BrdU/PSANCAM positive cells in the mouse 
subventricular zone. Single staining of BrdU (a-c); PSANCAM (d-f), Hoechst (g-i) in brain 
sections from control (a, d, g, respectively), hypoxic-ischemic (b, e, h, respectively), 
preconditioned hypoxic-ischemic (c, f, i, respectively) mice. Double-staining of BrdU and 
PSANCAM (j-k-l) in the subventricular zone of three groups. Scale bar 200 μm. High 
magnification of portions of dentate gyrus (m-n-o) Scale bar, 75 μm.  
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Figure 16. (A) Preconditioning induces the increase of total number of PSANCAM-positive 
cells in subventricular zone of hypoxic-ischemic mice. (B) The number of BrdU/PSANCAM-
positive cells decreases in the subventricular zone of hypoxic-ischemic and preconditioned 
hypoxic-ischemic mice compared to control group. Data represent the mean ± S.E.M. 
*P<0.05 versus control group; #P<0.05 versus hypoxic-ischemic group. The analyses were 
performed in five animals for each group. 
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4.6 HYPOXIC PRECONDITIONING INCREASES THE TOTAL 
NUMBER OF PSANCAM POSITIVE AND BrdU/PSANCAM POSITIVE 
CELLS IN DENTATE GYRUS OF MICE SUBJECTED TO HYPOXIC-
ISCHEMIC INJURY 
The effect of preconditioning stimulus (20‟ hypoxia) on endogenous 
neurogenesis was examined in dentate gyrus of mice subjected to hypoxic-ischemic 
injury. In particular, the differentiation of NSCs was detected through the analysis of 
proliferating BrdU+ cells. As previously described, all P7 mice were subjected to two 
intraperitoneal administrations of BrdU, and eventually, they were divided into three 
experimental groups: control, hypoxic-ischemic; and preconditioned hypoxic-ischemic 
mice. Then, the investigation of proliferating NSCs was performed by using 
immunohistochemical analyses with specific antibodies: anti-BrdU, anti-PSANCAM, 
and marker of nuclei Hoechst. BrdU antibody identifies the proliferating cells, which 
have incorporated the BrdU dose, while PSANCAM antibody allows to identify a 
membrane-bound glycoprotein expressed by neuroblast cells, double-staining of 
BrdU and PSANCAM marks the proliferating neural progenitors localized in 
neurogenic niches. The analysis of PSANCAM staining in dentate gyrus showed that 
there was a significant increase of PSANCAM positive cells in preconditioned 
hypoxic-ischemic mice compared to hypoxic-ischemic group. In addition, the analysis 
of BrdU/PSANCAM double staining demonstrated that there was a significant 
increase of BrdU/PSANCAM  positive cells in preconditioned hypoxic-ischemic mice 
compared to hypoxic-ischemic group (Fig. 17, 18)  
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Figure 17. Distribution of PSANCAM and BrdU/PSANCAM positive cells in the mouse 
dentate gyrus. Single staining of BrdU (a-c); PSANCAM (d-f), Hoechst (g-i) in brain sections 
from control (a, d, g, respectively), hypoxic-ischemic (b, e, h, respectively), preconditioned 
hypoxic-ischemic (c, f, i, respectively) mice. Double-staining of BrdU and PSANCAM (j-k-l) in 
the dentate gyrus of three groups. Scale bar 200 μm. High magnification of portions of 
dentate gyrus (m-n-o) Scale bar, 75 μm. 
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Figure 18. (A) Preconditioning induces the increase of total number of PSANCAM-positive 
cells in dentate gyrus of hypoxic-ischemic mice. (B) Preconditioning induces the increase of 
total number of BrdU/PSANCAM positive cells in dentate gyrus of hypoxic-ischemic mice. 
Data represent the mean ± S.E.M. *P<0.05 versus control group; #P<0.05 versus hypoxic-
ischemic group. The analyses were performed in six animals for each group.  
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4.7.1 HYPOXIC PRECONDITIONING DOES NOT IMPROVE 
PERFORMANCE IN RIGHTING REFLEX TEST OF MICE SUBJECTED 
TO HYPOXIA ISCHEMIA  
Short-term neurobehavioral functions were evaluated in pup mice by using 
specific neurobehavioral tests. Righting reflex test was performed in three 
experimental groups: control, hypoxic-ischemic, and preconditioned hypoxic-ischemic 
animals. Mice performance was monitored at different time intervals. In particular, 
mice were analyzed twice at postnatal day seven, with a time frame of 60 minutes. 
Afterwards, the test was replicated at postnatal day nine and before the sacrifice 
(P11). In the early phase of hypoxic preconditioning induction no difference was 
observed among three groups. At postnatal days eleven again no difference among 
three groups occurred. The animals always spent a similar time (sec) to perform trial 
(Fig. 19).  
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Figure 19. (A) The picture shows the pup placed in supine position, the time (in seconds) 
required to flip to the prone position was measured (B) Time course of righting performance 
in three experimental groups: control, hypoxic-ischemic, preconditioned hypoxic-ischemic 
mice. Data represent the mean ± S.E.M. The analyses were performed in control mice 
(n=12); hypoxic-ischemic mice (n=11); preconditioned hypoxic-ischemic mice (n=11). 
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4.7.2 HYPOXIC PRECONDITIONING IMPROVES PERFORMANCE IN 
CLIFF AVOIDANCE REFLEX TEST OF MICE SUBJECTED TO 
HYPOXIA ISCHEMIA 
The development of sensorimotor reflexes was evaluated in pup mice by using 
specific neurobehavioral tests. Cliff avoidance test was performed in three 
experimental groups: control, hypoxic-ischemic, and preconditioned hypoxic-ischemic 
hypoxic-ischemic animals. Mice performance was monitored at different time 
intervals. In particular, mice were analyzed twice at postnatal day seven, with a time 
frame of 60 minutes. Afterwards, the test was replicated at postnatal day nine and 
before the sacrifice (P11). In the early phase of hypoxic preconditioning induction no 
difference was observed among three groups. At postnatal day eleven 
preconditioned hypoxic-ischemic mice spent less time (sec) to perform trial than 
hypoxic-ischemic mice (Fig. 20).  
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Figure 20. (A) The picture shows the pup placed with its forepaws and chest extending over 
the board of table. The time (in seconds) required for pup to came back from the edge was 
measured (B) Time course of cliff avoidance performance in three experimental groups: 
control, hypoxic-ischemic, preconditioned hypoxic-ischemic mice. Data represent the mean ± 
S.E.M. *P<0.05 versus control and preconditioned hypoxic-ischemic groups. The analyses 
were performed in control mice (n=12); hypoxic-ischemic mice (n=13); preconditioned 
hypoxic-ischemic mice (n=13). 
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4.7.3 HYPOXIC PRECONDITIONING IMPROVES PERFORMANCE IN 
GEOTAXIS REFLEX TEST OF MICE SUBJECTED TO HYPOXIA 
ISCHEMIA  
The development of sensorimotor reflexes was evaluated in pup mice by using 
specific neurobehavioral tests. Geotaxis reflex test was performed in three 
experimental groups: control, hypoxic-ischemic, and preconditioned hypoxic-ischemic 
animals. Mice performance was monitored at different time intervals. In particular, 
mice were analyzed twice at postnatal day seven, with a time frame of 60 minutes. 
Afterwards, the test was replicated at postnatal day nine and before the sacrifice 
(P11). In the early phase of hypoxic preconditioning induction no difference was 
observed among three groups. At postnatal day eleven preconditioned hypoxic-
ischemic mice spent less time (sec) to perform trial than hypoxic-ischemic mice (Fig. 
21).  
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Figure 21. (A) The picture shows pup placed head downward on an inclined board (40◦). The 
time (in seconds) required for the pup to rotate their bodies head up (>90◦rotation) was 
measured (B) Time course of geotaxis performance in three experimental groups: control, 
hypoxic-ischemic, and preconditioned hypoxic-ischemic animals. Data represent the mean ± 
S.E.M. *P<0.05 versus control and preconditioned hypoxic-ischemic groups. The analyses 
were performed in control mice (n=12); hypoxic-ischemic mice (n=14); preconditioned 
hypoxic-ischemic mice (n=14). 
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4.8 EXPRESSION LEVELS OF NCX1 AND NCX3 PROTEINS DO NOT 
CHANGE IN THE IPSILATERAL HIPPOCAMPUS OF 
PRECONDITIONED HYPOXIC-ISCHEMIC AND HYPOXIC-ISCHEMIC 
MICE 
NCX1 and NCX3 expression was evaluated in the ipsilateral hippocampus of 
three experimental groups: control, hypoxic-ischemic, and preconditioned hypoxic-
ischemic mice, sacrificed at postnatal day eleven. Analyses were performed by using 
a western blotting technique.  
Data about protein expression of two NCX isoforms did not show any significant 
difference among three groups (Fig. 22).  
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Figure 22. (A) No difference of NCX1 expression levels exists between control and treated 
mice. (B). No difference of NCX3 expression levels exists between control and treated mice. 
Data represent the mean ± S.E.M. Analyses of NCX1 expression were performed in ten 
animals for each group. Analyses of NCX3 expression were performed in six animals for 
each group.  
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4.9 HYPOXIC PRECONDITIONING INDUCES NCX1 AND NCX3 
OVEREXPRESSION IN DENTATE GYRUS OF MICE SUBJECTED TO 
HYPOXIC-ISCHEMIC INJURY 
NCX1 and NCX3 expression was evaluated in ipsilateral dentate gyrus of 
three experimental groups: control, hypoxic-ischemic, and preconditioned hypoxic-
ischemic mice. Analyses were performed by using immunohistochemical technique. 
3,3′-diaminobenzidine (DAB) staining, performed by using specific antibodies direct 
against NCX1 and NCX3 proteins, indicated a different condition in a specific area of 
ipsilateral hippocampus. Interestingly, counting analysis revealed that there was a 
pronounced increase of NCX1 and NCX3 positive cells in preconditioned hypoxic-
ischemic mice compared to hypoxic-ischemic group. Cells are mainly localized in 
layer under granular cells, subgranular zone (Fig. 23, 24).  
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Figure 23. (A) Representative images of NCX1 positive staining of three mice groups have 
been shown. Scale bar 200 µm. (B) The number of NCX1 positive cells increases in the 
dentate gyrus of preconditioned hypoxic-ischemic mice compared to hypoxic-ischemic 
animals, sacrificed after 24 hours. Data represent the mean ± S.E.M. *P<0.05 versus control 
group; #P<0.05 versus hypoxic-ischemic group. The analyses were performed in three 
animals for each group. 
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Figure 24. (A) Representative images of NCX3 positive staining of three mice groups have 
been shown. Scale bar 200 µm. (B) The number of NCX3 positive cells increases in the 
dentate gyrus of preconditioned hypoxic-ischemic mice compared to hypoxic-ischemic 
animals, sacrificed after 24 hours. Data represent the mean ± S.E.M. *P<0.05 versus control 
group; #P<0.05 versus hypoxic-ischemic group. The analyses were performed in three 
animals for each group. 
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5 DISCUSSION 
In this project, we demonstrated that 20‟ hypoxia may represent a reliable and 
valid preconditioning stimulus in a mouse model of neonatal hypoxia ischemia. In 
fact, our data showed that this hypoxic preconditioning (HPC) delivered before a 
harmful insult is associated to endogenous neurogenesis in immature brain. 
Furthermore, since HPC induced NCX upregulation, the increase of neurogenic 
process may be linked to an ionic homeostasis maintenance, regulated by NCX 
proteins.  
In previous studies different times of hypoxia had been applied. Thus, in 2006, Pourié 
et al. demonstrated that a brief 5 minutes‟ hypoxic exposition, applied between 10 
and 24 hours after birth, was able to work as a preconditioning stimulus. In their 
study they showed that the hypoxic preconditioning prevented apoptosis induction in 
CA1 and DG hippocampal regions at different time intervals after hypoxia induction 
and induced an increase of cell density in these hippocampal regions 3 weeks after 
hypoxia induction (Pourié G. et al., 2006). The researchers also observed a transient 
increase of caspase-3 at 3 days after hypoxia, and according to Garnier et al. 
(Garnier P. et al., 2003), they reported that the activation of caspase-3 is crucial for 
triggering neuroprotection in ischemic preconditioning models. Finally, they observed 
the increase of neurogenesis in subventricular zone and in dentate gyrus of rats at 
P20 and P27 and suggested that these events were linked to an early activation of 
the ERK1/2 pathway (Pourié G. et al., 2006).  
In 2007, Yin et al. demonstrated, in a mouse model of neonatal hypoxia ischemia, 
that HPC induced the activation of the PI3-K/Akt signaling pathway and suppression 
of inflammation and these events protected cortex, hippocampus, and striatum 
against white matter injury, determining the significant reduction of tissue loss 24 
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hours and 7 days after HI induction (Yin W. et al., 2007). Our results obtained with 
20‟ hypoxia agree with Yin and Pourié‟s findings, since we observed a reduction of 
hippocampal damage in preconditioned hypoxic-ischemic mice 24 hours after a 
severe insult. Moreover, 3 days after hypoxia induction a severe hypoxic-ischemic 
insult induced a less brain infarct in preconditioned hypoxic-ischemic mice 24 hours 
after injury.  
Another interesting finding of our study that deserves to be underlined is that in DG 
there was an increase of neural stem cells marker, Nestin, already 24 hours after the 
induction of the stimulus. 
On this regard, it should be mentioned that in 2013 Ara and his colleagues 
demonstrated, in a piglet model of neonatal hypoxia ischemia, that hypoxic 
preconditioning increases neurogenesis in subventricular zone and new neuroblast 
cells migrate in striatum and cortex, 3 weeks after insult (Ara J. et al.,2013). In 
accordance to Ara et al. (2013), we observed a significant increase of neuroblast 
cells in the subventricular zone and a great number of proliferating neuroblast cells in 
dentate gyrus of preconditioned hypoxic-ischemic mice. Interestingly, in 
preconditioned hypoxic-ischemic animals the enhancement of neural progenitors was 
also associated with the improvement of the reflex performance. In particular, 24 
hours after severe insult the animals spent less seconds to perform geotaxis and cliff 
avoidance trials compared to hypoxic-ischemic mice. The improvement of 
neurobehavioral functions in preconditioned hypoxic-ischemic mice had been also 
observed in Sun‟s study (Sun HS. et al., 2015). In 2003, Ten and his colleagues 
analyzed the neonatal sensorimotor reflexes in a mouse model of hypoxia ischemia 
and demonstrated that the worsening in the performances could be associated with 
infarct volume enlargement (Ten VS. et al., 2003). In the present work we confirm 
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this result. In summary, in the first part of our study has been shown that 20‟ hypoxia 
functions as a preconditioning stimulus in neonatal hypoxic-ischemic mice, 
determining the reduction of hippocampal damage, the increase of neuroblast cells in 
neurogenic niches, and the improvement of sensorimotor reflexes.  
In the second part of the project, we investigated the relationship between the 
alteration of ionic homeostasis and the activation of endogenous neurogenesis 
mediated by NCX. Particularly, we focused our attention on hippocampal dentate 
gyrus because we observed the greatest increase of proliferating premature neurons 
(BrdU+/PSANCAM+) in this brain region.  
The choice of NCX lays on our previous works, showing that NCX1 and NCX3 
represent two new molecular effectors involved in adult brain preconditioning 
(Pignataro G. et al, 2012). In particular, we demonstrated that there was a significant 
reduction of infarct volume in preconditioned rats subjected to harmful ischemia and 
that the ischemic preconditioning induced NCX1 and NCX3 overexpression in the 
ipsilateral temporoparietal cortex (Pignataro G. et al, 2012). In addition, it has been 
demonstrated that the silencing of NCX1 and NCX3 genes prevented the 
neuroprotective effects mediated by ischemic preconditioning (Pignataro G. et al, 
2012). According to this previous study, we performed the counting of NCX1 and 
NCX3 positive cells in hippocampus and we demonstrated that a pronounced 
increase within dentate gyrus of preconditioned hypoxic-ischemic mice compared to 
hypoxic-ischemic group occurred. In particular, we observed that NCX1 and NCX3 
positive cells were mainly localized in the layer under granular cells, the so-called 
subgranular zone. The overexpression of NCX1 and NCX3 positive cells, induced by 
hypoxic preconditioning, probably represents a mechanism to reduce the intracellular 
alteration of ionic homeostasis. These findings are in accordance with previous 
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studies, in which it has been demonstrated that in neurons and glial cells there was 
an upregulation of NCX protein 72 hours after preconditioning induction (Pignataro G. 
et al., 2012). We speculate that this event occurs in order to counteract the 
dysregulation of intracellular Na+ and Ca2+ homeostasis triggered by harmful 
ischemia.  
The pivotal role played by NCX during preconditioning has been further highlighted in 
other recent papers. In particular, Sisalli et al. (2014) demonstrated, in primary 
cortical neurons, that IPC increased NCX1 and NCX3 protein expression 48 hours 
after OGD plus reoxygenation induction and this effect was mediated by NO 
production and PI3K/Akt activation. Therefore, the upregulation of NCX1 and NCX3 
activity mediated the endoplasmatic reticulum refilling and mitochondrial calcium 
extrusion, thus preventing intracellular calcium dysregulation induced by OGD (Sisalli 
MJ. et al., 2014). Furthermore, in 2015, Boscia et al. analyzed, by using both in vitro 
and in vivo models of adult ischemia, whether the sodium/calcium exchanger NCX1 
and calretinin, a Ca2+-binding protein, cooperate to confer neurons greater resistance 
to degeneration. They demonstrated that the neuroprotective effect of calretinin was 
correlated to NCX1 expression in striatal interneurons. Indeed, the silencing of 
calretinin in brain cells prevented the neuroprotection mediated by ischemic 
preconditioning and reduced the expression of NCX1 protein. In preconditioned brain 
was also observed an increase of AKT phosphorylation (pAKT) protein levels (Boscia 
F. et al., 2015). Moreover, in our laboratory, it has been demonstrated that treatment 
of PC12 cells and cortical neurons with neurotrophin NGF induced the 
overexpression of neuronal splicing from NCX1, NCX1.4. The expression and activity 
of this isoform reached the peak after 7 days of treatment, and this evolution was 
correlated with neuronal differentiation and neurite outgrowth (Secondo A. et al., 
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2015). In addition, in this paper it has been analyzed the correlation between the 
NCX1.4 overexpression and the activation of Akt-pathway. During neuronal 
differentiation induced by using of NGF treatment on PC12 cells, the authors proved 
that the great activation of sodium voltage-gated channels occurred. Then, the 
increase of intracellular levels of Na+ determined the activation of NCX1 reverse 
mode operation. Consequently, the increase of intracellular levels of Ca2+ and ER 
Ca2+ refilling occurred. These events determined the phosphorylation of Akt, that 
translocated into the nucleus and induced the transcription of molecules involved in 
the neuronal differentiation (Secondo A. et al., 2015). Therefore, it is possible to 
speculate that overexpression of NCX proteins might be involved in the increase of 
neuronal differentiation in this vivo model of hypoxic preconditioning.  
In conclusion, our results indicate that the hypoxic preconditioning is associated to 
endogenous neurogenesis in immature brain after insult. Indeed, this stimulus is able 
to trigger the proliferation of neural progenitor cells in the neurogenic niches. The 
increase of neurogenic process might be related to ionic homeostasis maintenance, 
regulated by NCX proteins. Therefore, NCX proteins can represent potential 
pharmacological targets for the treatment of brain damage associated to neonatal 
hypoxic-ischemic encephalopathy. 
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